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ABSTRACT 
 
Background & Objectives: The province of Newfoundland and Labrador (NL) has one 
of the highest rates of type 1 diabetes mellitus globally.  Diabetic ketoacidosis (DKA) is 
one of the major complications of this disease.  The Newfoundland and Labrador 
Diabetic Ketoacidosis Project (NLdkaP) is a multiphase project aimed at lowering the 
rates of DKA in the province. In order to assess the effectiveness of this project, we 
studied hospitalization rates for type 1 diabetes over a six–year period.  
Design, Setting & Measurements: This is a retrospective study carried out in NL using 
hospital administrative data covering the period January 1, 2009 – December 31, 2014 for 
patients aged ≤24 years.  Data extracted for each patient included demographic factors 
(e.g., sex and age), location of treatment, length of stay, and whether the patient has had 
recurrent DKA.     
Results: There were 412 patients admitted for DKA over the study period. DKA 
hospitalizations in the province decreased for the two years during the NLdkaP (2011 and 
2012; n = 107).  In the two years post project (2013 and 2014), DKA hospitalizations 
increased (n = 148) but rates did not increase to the initial rates measured before the 
project was implemented in (2009 and 2010; n = 157).   
Conclusions: The NLdkaP was associated with a decrease in DKA hospitalization rates. 
This knowledge translation project could be adopted by other regions to reduce the rates 
of DKA hospitalizations. Ongoing efforts are needed to sustain this preventative effect. 
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Chapter 1: Introduction 
Diabetes mellitus is a global health problem with increasing incidence rates 
occurring worldwide.  In Canada, 3.4 million people are estimated to have diabetes, 
which equates to approximately 9.4% of the population.171  This is higher than the 
estimated global prevalence of 8.5%,4 and the rate in Canada is forecast to rise to 5.0 
million or approximately 12.1% of the population by 2025.171  During the decade 
between 1998/99 and 2008/09, the prevalence of diagnosed diabetes in Canada increased 
by 70% (total prevalence changed from 3.3 – 5.6%).5  This rise in prevalence but not 
incidence is explained by the Public Health Agency of Canada (PHAC) as an indication 
of longer disease duration in those diagnosed with diabetes.5  PHAC further attributes this 
rise to improved care and treatment, but suggests it may also indicate earlier detection of 
those with undiagnosed diabetes or earlier age of onset.5  The increase in diabetes cases 
cannot be explained by genetic susceptibility alone and it is hypothesized to be due to 
environmental, lifestyle or other epigenetic factors that are triggering or accelerating the 
onset and progression of the disease.73  These factors point to the significant health 
burden that Canadians will face in relation to increasing rates of  diabetes.  
Diabetes is also one of the most common chronic diseases among children and 
youth.5  Type 1 diabetes mellitus (T1DM) (previously known as juvenile–onset or 
insulin–dependent diabetes mellitus) is the most common form of the disease observed in 
the pediatric age group; however, Type 2 diabetes mellitus (T2DM) (historically known 
as adult onset or non–insulin dependent diabetes mellitus) is also on the rise in both the 
pediatric and adult populations.  The majority of people with diabetes around the world 
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are affected by T2DM, and it is suggested that this is largely the result of excess body 
weight and physical inactivity.158  
In NL, the incidence of T1DM from 1987 – 2010 was 37.7 per 100,000.27  On 
average, one child or youth in NL is diagnosed with diabetes every week.3  According to 
the Canadian Chronic Disease Surveillance System, the number of youth diagnosed with 
diabetes increased significantly during the period from 2001 – 2008.3  This upward trend 
in incidence is alarming and calls for more focused investments in diabetes related 
research.  In 2007/08, it was estimated that 600 children and youth in NL were living 
with diabetes.3  Life expectancy can be decreased by as much as 15 years in those living 
with  with T1DM and between five and ten years for those living with T2DM.15  Thus, it 
is clear that efforts should be placed on better diabetes education and management as this 
has been shown to improve the health outcomes of individuals living with diabetes.    
There are significant costs associated with diabetes.  These costs include both 
direct treatment costs (e.g., hospitalizations, physician visits, medications) and indirect 
diabetes costs, including premature death and morbidity/disability related to diabetes and 
its complications.5  In Canada, these costs were projected to rise from $6.3 billion dollars 
in 2000 to $36.9 billion in 202015 (Figure 1).  In 2010, in NL, these costs were estimated 
to be $254 million, with a projected increase of 27% over the next decade to $322 
million17 (Figure 2).  Most of these costs were for adult patients, but children with T1DM 
also have significant treatment costs.  In NL, it is standard practice to hospitalize all 
newly diagnosed children and youth with T1DM, and it has been estimated that children 
and youth with diabetes are admitted to hospital 7.7 times more than those without 
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diabetes.3  These admissions are costly for both the health care system and the patients’ 
families. 
 
Figure 1: Cost of diabetes in Canada15 
                 
 
Figure 2: Cost of diabetes in NL17 
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Diabetes mellitus has many complications such as retinopathy, nephropathy, 
neuropathy and cardiovascular diseases.  Complications are estimated to account for 80% 
of total diabetes costs.15 One of the most serious and immediately life–threatening 
complications for patients with diabetes is diabetic ketoacidosis (DKA).  In DKA, a lack 
of an anabolic hormone called insulin renders the body unable to use glucose for energy.  
This leads to unopposed fatty acid breakdown, which produces ketones in the blood.  
Ketones contribute to the metabolic acidosis present in DKA patients.  DKA often 
requires hospital admission and intensive care management, and is associated with 
significant morbidity and increased mortality.  If not properly diagnosed, pediatric DKA 
can lead to cerebral edema.  Other possible complications of DKA are dehydration, 
myocardial infarction, necrosis of bowel tissue, kidney failure and even death, which 
occurs in less than 1% of patients in developed countries.21,56,106  DKA is still the most 
common cause of morbidity and mortality in children with diabetes and a common cause 
of hospitalization.6   
There are a number of different circumstances which can lead to DKA in a patient 
with diabetes.  A patient with undiagnosed diabetes may present for the first time to their 
doctor or an emergency room with DKA.  The diagnosis of DKA can initially be missed, 
especially in very young patients as the symptoms can mimic those of gastroenteritis or 
respiratory infection.  Patients already diagnosed with T1DM can develop DKA either 
through improper management of diabetes during times of illness or significant stress, 
improper management of their insulin pump or infusion site problems, and by non–
adherence and/or omission of insulin.30  While patients can suffer significant morbidity 
and mortality, the majority of cases of DKA can be prevented through early diagnosis of 
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diabetes as well as proper insulin management.132  Given the severity of DKA, emphasis 
should be placed on preventative efforts such as disease education and management.   
The NL DKA project (NLdkaP) is a multiphase knowledge translation project 
aimed at lowering rates of DKA in the province.  Launched in 2012, the NLdkaP 
provided information to educators, health care professionals, patients, their families and 
the general public on the significance of early detection and prevention of DKA.  This 
included the development of a continuing medical education course for physicians, focus 
groups for youth and their families dealing with diabetes (rural & urban settings), 
distribution of updated clinical information, DKA treatment protocols for emergency 
rooms, and DKA prevention toolkits for families affected by T1DM, as well as a broad 
publicity campaign.   
1.2 Study Rationale  
The cornerstone of diabetes care is providing education to patients and families 
about the disease and supporting them to develop better diabetes self–management 
skills.133  In the case of the NLdkaP, the education approach was multifaceted as it 
targeted healthcare professionals parallel to educating affected children, youth and their 
caregivers.  The NLdkaP made it a priority to directly provide education to affected 
children and youth to equip them with the knowledge and tools to better understand and 
effectively manage their T1DM.  The aim was to facilitate their T1DM management 
independence as they transition into older adolescence and adulthood and become 
increasingly less reliant on parental/caregiver support.   
The ultimate goal of the NLdkaP was to reduce the number of DKA episodes in 
the province and decrease its burden.  The current project aims to assess the effectiveness 
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of the NLdkaP and to determine whether DKA related pediatric hospitalizations varied 
before, during, and after the completion of the NLdkaP.  Demonstrating the effectiveness 
of a multiphase educational intervention such as the NLdkaP holds the promise of 
generating new knowledge about effective interventions seeking to prevent diabetes 
complications locally and in other regions and jurisdictions.    
1.3 Research objectives  
       The primary objective of this study is to analyze the effect of providing a multi–
component DKA health education intervention to health care professionals and 
patients/caregivers on hospitalization rates for pediatric DKA in the province.  This was 
accomplished by comparing hospitalization rates of children and youth diagnosed with 
DKA at three time periods over a six year period: two years before, during and after the 
intervention. Secondary objectives included measuring provincial and regional 
hospitalization rates of pediatric patients (age 0 – 18 years inclusive) presenting with 
diabetes and DKA and measuring provincial and regional hospitalization rates of patients 
aged 19 – 24 years (young adults) presenting with diabetes and DKA.  The reason for 
including this older age group is that this group of patients may have indirectly received 
some components of the intervention.  In addition, demographic factors of patients and 
multiple admissions for DKA were analyzed.     
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Chapter 2: Literature Review 
2.1 Search Strategy  
 A literature search was conducted using PubMed, Embase, the Cochrane Library, 
and CINAHL, with search terms pertinent to studies on diabetes education, specifically 
diabetic ketoacidosis education and prevention, tailored to each search engine.  Experts in 
the field of pediatric diabetes known to the author were also asked for their opinions 
regarding the search strategy and relevant literature.  The literature search was limited to 
English language articles; however, it was not restricted by date to ensure the information 
for review would give a complete overview of the history of the prevention of DKA and 
the progress made over time.  However, the main information sources for this paper were 
the most recent articles published in the period from 2000 to 2017.  The literature review 
provides background information on diabetes with emphasis on T1DM and DKA, factors 
contributing to the development of DKA, and existing DKA prevention studies.  While 
not part of the literature review, but to provide a context of this study, a more in–depth 
explanation of the NLdkaP will also be included in this chapter.  
2.2 Diabetes Mellitus   
Diabetes was first described in 1552 B.C. by the Egyptian physician Hesy–Ra of 
the 3rd Dynasty.1  In the papyrus documents that were found, Hesy–Ra described the 
condition of “passing too much urine” and possible remedies for this.  Throughout the 
centuries, scientists have written about their discoveries and understanding of diabetes, 
including its management, which, at a time, included using a starvation or fasting diet as 
treatment options.  It was not until 1921 that Sir Frederick Banting and his colleagues co–
discovered insulin and its therapeutic potential.170  Since then, many improvements and 
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technological advancements have been made, including the availability of various types 
of insulin and insulin delivery devices, pancreatic cell transplants and glucose monitoring 
systems, all of which have revolutionized the management of diabetes.  However, a cure 
remains elusive.  
Diabetes mellitus is a chronic disease characterized by the body’s inability to 
produce or effectively use insulin.  Insulin is a naturally occurring peptide hormone 
produced by the beta cells in the Islets of Langerhan, which are a cluster of pancreatic 
cells.  The various islet cells work together to regulate blood glucose levels.  The primary 
function of insulin is to facilitate the entry of glucose from the bloodstream into cells.  
Glucose is then used in intracellular energy metabolism.  It is produced and stored in the 
body as a hexamer, while the active form is a monomer.  The hexamer form is useful for 
long–term sustainability.  Since this form is less reactive than the monomer form, it keeps 
insulin protected while being readily available for use.9  Human insulin is a peptide 
hormone composed of 51 amino acids with the chemical formula C257H383N65O77S6 and a 
molecular weight of 5808 Daltons.14  It is a dimer of an alpha–chain and a beta–chain 
which are linked together by disulphide bonds.13,14  The alpha chain has 21 amino acids 
and the beta chain has 30 amino acids.13  A lack of glucose uptake from the bloodstream 
causes hyperglycemia, which can lead to a myriad of complications, including nerve and 
blood vessel damage.   
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Figure 3: Primary amino acid sequence of human insulin147 
There are two main types of diabetes mellitus in the pediatric and young adult 
population: Type 1 and Type 2.  T1DM is characterized by the inability of beta cells to 
produce insulin.  It was formerly called insulin–dependent diabetes, juvenile or childhood 
onset diabetes.2  Its cause remains unknown and it is not preventable.2  T1DM is a 
chronic autoimmune disease characterized largely by T cell–mediated destruction of 
insulin–producing pancreatic beta cells.  Individuals become hyperglycemic and 
symptomatic when a critical amount of beta cell mass is lost and the residual beta cell 
mass is unable to match insulin demand.3  T2DM is characterized by insulin insensitivity.  
Previously used terminology included non–insulin dependent (NIDDM) or adult–onset 
diabetes, and it is largely associated with excess body weight and physical inactivity.2   
The presenting symptoms of both types of diabetes are similar; however, those associated 
with T2DM often arise more gradually and, as a result, the disease is often not diagnosed 
until complications occur.135  Common symptoms of diabetes mellitus include polydipsia, 
polyuria, weight change, extreme fatigue and lethargy, blurred vision, frequent or 
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recurring infections, cuts and bruises that are slow to heal and tingling or numbness in 
extremities.1   
After decades of research involving over 160,000 individuals, the Juvenile 
Diabetes Research Foundation, the American Diabetes Association and the 
Endocrinology Society developed new guidelines for diagnosing T1DM, as a way to 
improve diagnostic timelines.  The three distinct stages aid in a better understanding of 
how T1DM progresses in order to diagnose the disease in its earliest stages and provide 
prompt intervention.143  T1DM progresses in the following three stages:134   
Stage one: Individuals are screened for diabetes–related auto–antibodies.  If an individual 
tests positive for two or more auto–antibodies, they are considered to be in stage one.  
This stage is indicative that the immune system has started attacking insulin–producing 
beta cells, although blood sugar levels remain normal and no symptoms are present. 
Stage two: Individuals have tested positive for two or more diabetes–related auto– 
antibodies, but their blood sugar levels have become abnormal due to the increasing loss 
of beta cells.  There are still no symptoms. 
Stage three: At this stage, the immune system has already destroyed a very large number 
of beta cells.  In addition to diabetes–related auto–antibodies and abnormal blood sugar 
levels, T1DM symptoms are usually present. 
In contrast, the pathophysiology of pediatric T2DM is not completely understood; 
however, it is characterized by insulin insensitivity due to insulin resistance and a decline 
in insulin production, ultimately resulting in pancreatic beta–cell failure.  This leads to a 
decrease in glucose transport into liver, muscle and fat cells.134, 138      
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On a global scale, in 2014, both T1DM and T2DM affected over 420 million 
people, accounting for 8.5% of the population over 18 years of age.  This figure is almost 
quadruple from the 108 million affected in 1980.4  In 2012, diabetes directly caused 1.5 
million deaths and an additional 2.2 million deaths indirectly (by increasing the risk of 
cardiovascular and other diseases).2  In Canada, diabetes affected over 3.4 million people 
in 2015.171  According to the Public Health Agency of Canada, data obtained from blood 
samples showed that approximately 20% of cases remain undiagnosed.5  It is estimated 
that when combined with undiagnosed diabetes and pre–diabetes, about one in three 
Canadians will be affected by 2025.6  Newfoundland and Labrador (NL) has one of the 
highest rates of diabetes in the country, accounting for approximately 47,000 individuals 
in 2010 (9.3% prevalence rate) and estimated to rise to 73,000 in 2020 (14.4% prevalence 
rate).6           
 Diabetes and its complications bring about substantial economic loss to people 
with diabetes and their families.  Further, the disease impacts health care systems and 
national economies through direct medical costs and loss of work and wages.4  It is 
estimated that individuals with diabetes have 2.3 times the healthcare costs than 
individuals without diabetes, and that one in every ten healthcare dollars is spent on 
individuals with diabetes.10  Globally, as of 2016, the cost of diabetes reached $825 
billion per year, not including work days lost.16  Nationally, the Canadian Diabetes 
Association reported that in 2010, diabetes–related costs impacting the healthcare system 
and the economy was $11.7 billion with projections rising to $16 billion by 2020.15  In 
NL, the economic burden of diabetes was estimated to be $254 million in 2010.  This cost 
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is expected to increase by a disquieting 27% over only one decade to $322 million by 
2020.17  
Given that currently there is no cure for diabetes, it is imperative that healthcare 
providers acquire sound knowledge and competencies for the diagnosis and treatment of 
the disease.  Diabetes management can be strengthened through the use of standards and 
protocols.4,7  However, to lower both the health and economic burden associated with 
the disease, diabetes education should extend to patients, their families and the general 
public.             
  
2.3 T1DM in Canada and NL        
 Childhood T1DM is one of the most prevalent pediatric chronic diseases in the 
world.29 The incidence of T1DM in children is well documented,98,99 varying from 
0.1/100,000 person–years (P–Y) in Venezuela and China to more than 36/100,000 P–Y in 
Finland and Italy from 1990 – 1994.104  The latter two countries also reported rates of 
45/100,000 P–Y in 1996.99  There are a number of Canadian studies reporting the 
incidence of T1DM in children, including two studies based on urban tertiary hospital 
populations in Montreal100 (10.1/100,000) and Toronto101 (9/100,000), and three 
population–based studies using data collected from the provincial drug registry in Prince 
Edward Island102 (24.5/100,000), the Manitoba Diabetes Database in Manitoba103 
(20.4/100,000) and Alberta105 (20.4/100,000). 
 A 2004 population–based study carried out by Newhook et al. in NL reported that 
the province had the highest incidence rate of childhood T1DM in North America28 and 
the third highest recorded worldwide.28-30  Another study conducted in NL examined data 
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from 1987 – 2010 and found that the incidence of T1DM in the province rose during this 
time interval.  A prospective study showed that from 1987 to 2005 the incidence rate was 
37.7/100,000, but during the period 2007 – 2010 the incidence rate was found to be 
49.9/100,000.27  While T1DM is a genetically linked disease, this large rise cannot solely 
be attributed to heredity.29  It is hypothesized that some environmental, epigenetic and 
lifestyle factors play a critical role.       
 Parallel to the rising rate of T1DM in NL, there is also a documented increase in 
hospitalization rates related to T1DM in the province.  In the period 1995 – 1996, the 
hospitalization rate was 84.5/100,000.  By 2001 – 2002, it had climbed to 103.8/100,000, 
a relative increase of 18%.29  Investigating the hospitalization rates for T1DM is 
important in determining the overall burden of illness and the need for health services.29  
There is a large variation in diabetes hospitalization rates and length of stay between 
countries and different time periods, which may be attributed to differences among health 
care systems.  In northern European countries, hospitalization rates among patients with 
diabetes were higher than those in the United States.99  In comparison with other 
jurisdictions, the overall hospitalization rate of T1DM in NL is higher than Ontario 
(68.4/100,000)106, California (31.9/100,000)107 and The Netherlands (25.2/100,000)108. 
2.3.i Genetics and T1DM  
As already discussed, T1DM is attributed to both genetic and environmental 
factors.  In NL, the population is primarily comprised of descendants from approximately 
20,000 English and Irish immigrants who settled in the province in the mid–1700s.109  
The immigration history of NL is well documented, concluding that approximately 96% 
of residents have ancestors from southeast Ireland or southwest England.110  Most of the 
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settlers in NL were attracted to the cod fishery, which peaked in the late 18th and early 
19th centuries.  This was the last major in–migration, bringing the population of NL to 
around 75,000 in the mid–1830s.  Since this time, natural growth has been the main 
source of population increase.  The NL populace is considered to be relatively 
homogeneous due to geographic isolation, previous lack of roads, religious segregation, 
scarce intra–provincial migration and limited immigration and emigration; all of which 
kept related families together.110,111,114  Interestingly, the incidence of T1DM is still high 
in ancestral England and Ireland, but is lower than in NL.  For example, epidemiologic 
studies show that the incidence in the Republic of Ireland was (16.6/100, 000) in 1997,112 
and the incidence in Devon and Cornwall, England was (16.1/100, 000) from 1975 – 
2001.113  Several studies conducted in NL highlighted the link between genetic–based 
diseases and founder effects.115,116  This association is hypothesized to be relevant in 
T1DM, potentially contributing to the high incidence rate in the province.111  However, 
the steep incidence rise (37.7 to 49.9/100,000) over a relatively short period of time 
cannot be solely attributed to founder effects.  Therefore, environmental factors are a 
reasonable assumption as contributing elements in an already genetically at–risk 
population.111   
2.3.ii Environment and T1DM  
A prospective and retrospective cohort study of the incidence of T1DM in NL in 
children aged 0–14 years from 1987 to 2005 determined a number of possible 
environmental factors related to T1DM.111  First, the study noted that the development of 
T1DM may be related to the early infant diet.  Studies have shown that infants who are 
breastfed are less likely to develop T1DM.180  Most infants in NL are formula fed (cow’s 
 15 
milk protein–based) and breastfeeding initiation and duration rates are low, despite rising 
over the study period (36 – 64%).123,124       
 Second, there is a hypothesized correlation between vitamin D metabolism and 
various autoimmune diseases, including T1DM.117-122  Given the northern geographic 
location of NL, sun exposure is minimal, resulting in less endogenously produced vitamin 
D.125  Less hours spent outdoors and use of sunscreen on infants and toddlers are also 
suspected to affect vitamin D synthesis.111  Further to this latitude–based hypothesis, the 
researchers compared incidence between geographic regions and found that the Northern 
Peninsula of NL had the highest incidence of T1DM (43.2/100, 000) while the South 
Coast of NL had the lowest incidence (18.3/100, 000).111     
 Another potential environmental influence identified in the literature is the 
association of T1DM and high rates of obesity.126-128  The rates of being overweight and 
obese in NL are documented as the highest in Canada and rising.129  Other studies suggest 
that high birth weight, increased height, weight and body mass index are likely risk 
factors in the development of T1DM, and are likely factors contributing to the high rates 
of T1DM in NL.130,131   
2.4 Diabetic ketoacidosis         
  
Diabetic ketoacidosis (DKA) is an acute and life threatening complication of 
diabetes and is the leading cause of morbidity and mortality in children with diabetes.22    
It is the most common pediatric metabolic emergency.23  It is defined as a blood glucose 
concentration of >11 mmol/L, with ketonemia/ketonuria and a venous pH <7.3 or 
bicarbonate <15 mmol/L.26,148  Insulin deficiency is the primary defect, causing elevated 
serum glucose and lipolysis, which leads to ketone formation.  Secondary defects such as 
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psychological stress caused by acidosis and progressive dehydration and coexistent 
infection or illness can stimulate the release of counter–regulatory hormones.  These 
hormones include catecholamines, cortisol, growth hormone and glucagon and they 
contribute to increased serum glucose through increased hepatic glucose production and 
impair peripheral glucose uptake.148  Epinephrine promotes lipolysis and free fatty acid 
release through the activation of adipose tissue hormone–sensitive lipase in adipocytes.148  
This mechanism results in the accumulation of acidic intermediate and end metabolites, 
which are toxic to the body at high levels.  Ketone bodies are produced from acetyl 
coenzyme A mainly within hepatocytes in the mitochondria.  High levels of acetyl 
coenzyme A present in the cell inhibit the pyruvate dehydrogenase complex, but activate 
pyruvate carboxylase.  Thus, the generated oxaloacetate enters gluconeogenesis rather 
than the citric acid cycle, as the latter is also inhibited by the elevated level of 
nicotinamide adenine dinucleotide (NADH) resulting from excessive β–oxidation of fatty 
acids.  The excess acetyl coenzyme A is therefore rerouted to ketogenesis.34  There are 
three ketone bodies responsible for DKA, β–hydroxybutyrate (78% proportion in the 
blood), acetoacetate (20%) and acetone (2%).26  It should be noted, however, that only 
acetone is a true ketone, while β–hydroxybutyrate is a hydroxy acid and acetoacetate is a 
ketoacid. 34  DKA is characterized by the triad of hyperglycemia, metabolic acidosis and 
increased total body ketone concentration; and stems from absolute or relative insulin 
deficiency.7  The severity of DKA is defined by the degree of acidosis: mild, venous pH 
7.2–7.3; moderate, pH 7.1–7.2; and severe, pH <7.1.8   
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Figure 4: B-hydroxybutyrate, the main ketone in DKA9 
 
As discussed above, DKA is the outcome of absolute or relative deficiency of 
circulating insulin combined with the effects of increased levels of the counter–regulatory 
hormones catecholamines, glucagon, cortisol and growth hormone.31,32  Absolute insulin 
deficiency may occur in previously undiagnosed T1DM and/or when a patient 
undergoing insulin treatment deliberately or unknowingly fails to take insulin.  This is 
especially the case if the long–acting insulin is omitted.26  Patients who use an insulin 
pump can rapidly develop DKA when insulin delivery fails for any reason because only 
rapid-acting insulin is being used.33  On the other hand, relative insulin deficiency arises 
when the concentrations of counter–regulatory hormones increase in response to stress in 
conditions such as sepsis, trauma, or gastrointestinal illness with diarrhea and vomiting.  
The combination of low serum insulin and high counter–regulatory hormone 
concentrations results in an accelerated catabolic state with increased glucose production 
by the liver and kidney (via glycogenolysis and gluconeogenesis), impaired peripheral 
glucose utilization resulting in hyperglycemia, hyperosmolality, increased lipolysis and 
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ketogenesis causing ketonemia and metabolic acidosis.26  DKA causes severe water and 
electrolyte depletion from both the intra and extracellular fluid compartments.26  Table 1 
below depicts the range of fluid losses.   
Figure 5: Pathophysiology of DKA8 
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Table 1: Fluid and electrolyte loss in DKA26 
  
   
  In patients newly diagnosed with T1DM, the most common symptoms for DKA 
include polyuria, polydipsia, weight loss and nocturia as well as neurologic symptoms 
such as irritability and altered levels of consciousness.  In previously diagnosed 
individuals, the most common symptoms of DKA are vomiting and abdominal pain.30  If 
the presenting symptoms are left untreated, they can escalate into tachycardia, 
hyperventilation, vomiting, dizziness, confusion, fruity breath, drowsiness and 
unconsciousness.            
  Some complications of DKA can be exacerbated by inappropriate medical 
management such as giving too much or the wrong types of intravenous fluids.38   
Physicians must be judicious when restoring fluids along with the necessary electrolytes 
such as sodium, potassium and chloride and when administering insulin.  For example, 
insulin infusions allow glucose to enter the cells, and if too much insulin is given, blood 
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glucose levels can drop too quickly and hypoglycemia may occur.  Further, intravenous 
fluids and insulin infusion may cause potassium levels to drop, a condition called 
hypokalemia.  Hypokalemia can impair the heart, muscle and nerve function.  Finally, 
rapid changes in osmolarity can contribute to cerebral edema.38  Despite these common 
and serious complications, leaving DKA untreated is fatal.  To avoid the development of 
DKA, it is critical to understand and be able to detect the most common presenting 
symptoms of diabetes.30     
2.4.i Differences in adult and pediatric DKA  
While the fundamental pathophysiology of DKA is very similar in adults and 
children, there are a number of reasons why DKA is different in a pediatric population.  
Considering these differences is integral in developing DKA awareness and education 
programs tailored to health care personnel, patients and families.  In 2006, Wolfsdorf and 
al8 reported that it is challenging to detect a history of polyuria and polydipsia in young 
children.  Consequently, the preschool age group are often misdiagnosed with 
pneumonia, bronchiolitis, gastroenteritis or other common childhood diseases.  
Sometimes they are treated with glucocorticoids, which further exacerbate metabolic 
imbalances that are present in DKA.  Also, children have a higher basal metabolic rate 
and large surface area relative to total body mass.  This requires greater precision in 
delivering fluids and electrolytes.  Cerebral and other auto–regulatory mechanisms may 
not be as well developed in children.  Hence, in a younger population, greater symptom 
severity at presentation in combination with less developed auto regulatory systems 
predispose children to cerebral edema, which occurs in approximately 0.5 – 1% of all 
episodes of pediatric DKA.8  Cerebral edema is a very serious DKA complication.  
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Although its pathophysiology is related to dehydration and acidosis, its causes are 
multifactorial and not fully understood.  Increased levels of inflammation and coagulation 
are hypothesized to lead to decreased blood flow to areas of the brain, which then swell 
once fluid replacement is initiated.11  Cerebral edema is more likely to occur in patients 
with severe DKA, who are younger (<5 years of age), and are having their first episode of 
DKA at diagnosis.11,12  It is estimated that it is three times more likely to occur in those 
with new onset diabetes.20  Cerebral edema is the most common cause of mortality in 
children with DKA,18-21 accounting for 60 – 90% of all DKA–related deaths in the 
pediatric population.7,8  Preadolescent DKA occurs most often in children with previously 
unrecognized diabetes (delay in diagnosis), whereas omission of insulin is the leading 
cause of DKA and recurrent DKA amongst adolescents and young adults.8   
2.5 Factors contributing to the development of DKA  
DKA can be primary or secondary: 1) primary DKA is at initial diagnosis of 
T1DM and 2) secondary DKA which occurs in those with established diabetes as a result 
of accidental or deliberate insulin omissions, at times of stress such as intercurrent illness, 
and/ or inappropriate management.38  DKA at initial presentation is common, however, 
rates vary greatly among countries, ranging from 15 – 70%.7,9,34,35,36  Similar variability 
across jurisdictions applies to DKA in children with previously diagnosed T1DM.36,37  
DKA is mainly associated with T1DM however, it can also occur in individuals with 
T2DM.136  An imperative point to know is that most, if not all, cases of DKA are 
preventable.21,22  Prevention of DKA by proper insulin management and early detection 
of diabetes in new patients should reduce the severity and rates of DKA.       
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 A systematic review conducted in 2011 identified 46 studies, including more than 
24,000 children with T1DM from 31 countries.23  It is unclear why some children present 
in DKA whereas others do not, and whether the development of DKA is a consequence 
of delayed diagnosis and treatment or whether it reflects a particularly aggressive form of 
diabetes.164  Exploring the underlying factors associated with DKA is therefore integral to 
developing a better understanding of the disease and how to inform individuals, families 
and healthcare professionals.   
 A number of studies worldwide examined the risk factors leading up to an 
individual developing DKA.  These factors have been grouped into the following 
categories: 1) Individual; 2) Family; 3) Physician–related; 4) Disease–related; 5) Other 
and 6) Protective.  The ensuing paragraphs discuss these influences and are summarised 
in Table 2.      
 
INDIVIDUAL FACTORS 
1. Age 
 Previous research has shown that younger age at T1DM diagnosis is a significant 
risk factor in the development of DKA.  Usher–Smith et al. found that children under two 
years of age had three times the risk of presenting with DKA than children older than two 
years of age (OR 3.41; 95% Confidence Interval (CI), 2.54 – 4.59) and this continued up 
to five years of age (OR 1.59; 95% CI, 1.38 – 1.84).38  It has been determined that the 
frequency of DKA decreases with age from 37 – 40% (95% CI, 32.9% – 41.8%) in 
children up to four years of age, to 15 – 24% (95% CI, 11.7% – 17.7%) in children 15 to 
19 years of age.40,41  There are a number of suspected reasons for the higher rates of DKA 
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in younger age groups.  First, the classic signs of T1DM may not be as obvious, therefore 
causing a delay in diagnosis.  In addition, young children are unable to speak and 
verbalize their symptoms.  Second, clinicians may have lower rates of suspicion of 
T1DM in younger children.42,43  These conclusions could also be considered under the 
“Physician–related” heading.  Third, younger children have less developed mechanisms 
of metabolic compensation, thus DKA manifests at a much faster rate.40,44  Finally, in 
children < 2 years of age, β–cell destruction may be more aggressive as indicated by low 
serum levels of C–peptide found in younger versus older children.44,46  In adolescents, 
factors associated with DKA occurrence may be attributed to the teen’s growing 
independence and less time spent with parents/guardians and family.  They may be more 
likely to ignore signs and symptoms and in those with T1DM there may be higher rates of 
non–adherence to medical treatment and insulin mismanagement.  Other confounding 
factors in this older age group are psychological factors, such as intentional weight 
restriction and eating disorders, which can lead to poor glycemic control and higher risk 
of DKA.   
 
2. Sex 
Prior studies have shown the association between sex and DKA frequency.  In 
particular, DKA occurrence was found to be higher in females.29,30,50,64  Although these 
studies did not look at specific reasons as to why this may be, it is suggested that there 
are psychosocial factors involved, such as familial conflict, behavioral issues and 
intentional weight reduction associated with insulin omission.74,75  As well, in one study, 
females were found to have a higher mean HbA1C level.30  HbA1C levels are measured 
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by blood test and indicate the percentage of haemoglobin that is glycated.149  The test 
result reflects blood glucose levels over the preceding few months, rather than at one 
point in time, thus shedding light on overall diabetes management.  While HbA1C levels 
can vary slightly between individuals, a higher level indicates poor glycemic control 
(ideal is ≤ 7.0).142,149  Another study showed that being female was significantly 
associated with an increased chance of delayed diagnosis with a symptomatic period ≥4 
weeks (OR 2.78 (1.09 – 7.14), P = 0.033).59  Interestingly, in this study, delayed 
diagnosis was not associated with an increased risk of severe DKA (pH < 7.1; 
bicarbonate < 5 mmol/L, OR 0.68; 95% CI, 0.26 – 1.83, P = 0.450).
59   
 
3. Ethnic minority 
 Studies have demonstrated an increased risk of DKA among ethnic minorities.  
Most of the studies conducted had such a heterogeneous pool of patients that establishing 
whether the frequency of DKA was significantly different in any particular race or ethnic 
group was difficult.  However, in studies comparing the frequency of DKA between two 
different ethnic groups, all showed a significant difference in the frequency of DKA, and 
further, in each case, the ethnic minority group experienced an increased risk of DKA.38  
A multicenter study conducted in the United States (US) found that independent of 
socioeconomic status and age, non–Caucasian youth were at higher risk of presenting 
with DKA at diagnosis when compared with non–Hispanic Caucasian youth (OR 1.21; 
95% CI, 1.03 – 1.43).47  A number of other US studies researched ethnic background and 
its relation to DKA risk.  The results showed the DKA risk for non–Hispanic Caucasian 
people compared with others (OR 0.55; 95% CI, 0.32 – 0.96),71  Caucasian people 
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compared with Hispanic (OR 0.33; 95% CI, 0.14 – 0.76)72 and non–Hispanic Caucasian 
compared with Hispanic (OR 0.58; 95% CI, 0.37 – 0.89).73  A study in the United 
Kingdom (UK) demonstrated more frequent DKA at diagnosis of T1DM among ethnic 
minorities compared with non–Hispanic Caucasian patients (41.3% vs. 21.4%, P = 
0.03).48  Finally, a study in New Zealand showed that non–Europeans were more likely to 
have DKA at diagnosis than Europeans (OR 1.52, P = 0.048).49  Cultural differences, 
language barriers, lack of access to health care services and lack of awareness of T1DM 
are all factors that may contribute to the disparity that exists between minority and non–
minority populations.  Based on these observations, an effective DKA prevention 
program should be developed in a way to reflect considerations on ethnic minority and 
surrounding issues.  
 
4. Body mass index (BMI) 
Studies conducted in Austria and Finland both included BMI as a risk factor of 
DKA.  Both of these studies concluded that a lower BMI is associated with a higher risk 
of developing DKA.69,70  These findings are in line with the psychosocial/psychological 
factors discussed in the age and sex categories above, as weight loss due to insulin 
omission can lead to poor glycemic control and increased risk for DKA. 
 
5. Psychological stress 
When the body is under short or long term stress, the counter–regulatory 
hormones such as catecholamines, cortisol, growth hormone and glucagon are released.30    
A study conducted by MacGillivray et al. concluded that the rapid onset of DKA in 
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patients who reported emotional stress suggests that stress was the trigger for the release 
of large amounts of counter–regulatory hormones which overwhelmed and inhibited the 
physiologic action of insulin.  While these hormones inhibit or overwhelm the action of 
insulin at one or more of its target tissues, it is also likely that the prescribed and usual 
dose of insulin in these patients was insufficient to offset the effects of these counter–
regulatory hormones, and without increasing the dosage of insulin, DKA ensued.173   
 
6. Non–adherence to insulin management 
 Insulin mismanagement can be deliberate or accidental.  It has been shown to 
occur in youth, and more often females, who are restricting their weight (as mentioned in 
the age and sex sections).  It has also been shown to occur in youth as they take on more 
responsibility for the management of their own condition, but falter on occasion.  This 
could be in part due to immaturity or simply not having enough education and/or 
understanding about when and how to deal with issues that may arise (e.g., pump 
failures).  As well, a lack of understanding regarding the consequences of not acting in a 
timely manner may be relevant.  Finally, there is a higher risk of entering into DKA when 
children are under the temporary care of people other than their parents or guardians who 
may not know how to properly administer insulin (for example, when managing sick 
days141,142).  It is imperative for proper education and re–education of both the individual 
with diabetes and those around them to ensure that issues of insulin mismanagement do 
not occur, and are quickly addressed if they do arise. 
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FAMILY FACTORS  
1. Lower socioeconomic status   
Socioeconomic status as measured by family income or neighbourhood income is 
associated with an increased risk of DKA at diagnosis.47,50  An American study by 
Dabelea and colleagues found that the frequency of DKA was 70 – 80% higher in 
patients with family income below $50,000 when compared to those with family income 
above $50,000.47  This finding applies to patients in Canada even in light of having 
universal access to healthcare.  A Canadian study found that patients with low 
socioeconomic status, measured by neighbourhood quintiles, were more likely to present 
with DKA at diagnosis when compared with those living in higher income quintiles (OR 
1.39; 95% CI, 1.17 – 1.63).50      
 
2. Lack of private health insurance  
Lack of private health insurance has consistently been found to be a significant 
risk factor for DKA at diagnosis.51-53  A study in the United States concluded that patients 
with private health insurance were least likely to present with DKA.51  King et al. found 
that patients without private health insurance were 60% more likely to present with DKA 
compared to those with private health insurance.  When uninsured patients presented with 
DKA, they were more likely to present with severe DKA (venous pH < 7.10; serum 
bicarbonate < 5mmol/L).53  The odds of uninsured patients presenting with severe DKA 
were six times greater than for insured patients (OR 6.09; 95% CI, 3.21 – 11.56).52  
Children in the US with no insurance also had a greater risk of presenting in DKA 
compared with those receiving Medicaid (OR 2.84; 95% CI, 1.16 – 6.93), but there was 
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no difference between those with private insurance and those receiving Medicaid (OR 
0.54; 95% CI, 0.26 – 1.10).71  These findings suggest that uninsured patients are more 
likely to delay a hospital visit, which is consistent with a delayed diagnosis that can lead 
to more severe cases of DKA.     
 
3. Parental formal education 
Several studies from Baltic countries found that if a child’s mother had higher 
than secondary education, it was a protective factor against the occurrence of DKA (OR 
0.4; 95% CI, 0.20 – 0.79).95  As well, children from families that had at least one parent 
with an academic degree were found to have lower incidence of DKA at presentation 
than those without (16.9% (43/254) vs 24.4% (105/431), P < 0.05, OR 0.64; 95% CI, 
0.43 – 0.94).45  Finally, children from families in which parents had ≤9 years of education 
had a significantly increased risk of severe DKA (OR 3.54; 95% CI, 1.10 – 11.35, P = 
0.034) compared with children whose parents had ≥ 12 years of education, even after 
adjustment for rates of delayed diagnosis.59 
 
4. Family structure 
A few studies considered family structure as a factor of DKA, including having a 
single parent and the number of children in the family. Neither of these considerations 
were found to be associated with an increased risk of DKA.59,68,94  
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5. Rural / urban residence  
Various studies have found that there is no difference in DKA occurrence 
between living in an urban or rural setting.95,139  However, in NL, it is thought that living 
in a rural area does increase the odds of DKA occurrence.160  This can be attributed to 
lower T1DM incidence and/or less DKA education (both for the public and for 
physicians) and due to less access to resources, resulting in missed or delayed diagnosis.  
In some communities, limited access to health care workers such as social workers, 
psychologists, psychiatrists, diabetes educators and dietitians may be part of the cause.160  
In a recent 2015 study, despite the geographic isolation and lack of resources that rural 
NL residents reported, they responded positively to community supports that were 
available in their hometowns, such as support groups.160  Further, some rural residents 
commented that living in a small place allows for stronger community ties and social 
support which helped their children with diabetes.160   
 
PHYSICIAN–RELATED FACTORS 
1. Delayed diagnosis 
An NL study by Jackman et al. found that a delay in diabetes diagnosis is one of 
the leading causes of DKA in children.  In this 2015 study, the rate of DKA on 
presentation for incident cases of diabetes in NL was 22.1% in the region’s tertiary care 
hospital.21 Based on other study findings, DKA diagnosis on initial presentation of new 
onset T1DM occurs between 15 – 70% of the time.34,36  There are a number of factors 
which can lead to delays in diagnosing diabetes.  A study from the UK reported that a 
delay of more than 24 hours between initial presentation to a primary or secondary care 
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provider and referral to a multidisciplinary diabetes team is associated with an increased 
risk of presenting with DKA (52.3% vs 20.5%, P < .05).48  The most common reason for 
a delayed diagnosis was arranging a fasting blood sugar test prior to referral to a 
multidisciplinary team.48  Regions having higher rates of T1DM generally have lower 
rates of DKA at the time of diagnosis, according to findings from a number of 
studies.81,21  This may be related to heightened awareness of DKA in areas with higher 
prevalence of T1DM.  Bui et al. reported that children with DKA at diabetes diagnosis 
were more likely to have visited a health care professional on one or more occasions in 
the weeks prior, at which time diagnosis of T1DM was missed.30,50  Further, 39% of 
children and adolescents with new onset diabetes who present in DKA had seen a 
physician in the preceding week.50     
  
2. Diagnostic error  
Several studies have reported an increased risk of DKA in children not diagnosed 
with T1DM at first presentation to the health care system either due to misdiagnosis or 
lack of recognition of the symptoms of T1DM.48,50  Independent of preceding infection, 
diagnostic error has been associated with a three–fold increased risk of presenting with 
DKA (OR 3.35; 95% CI, 2.35 – 5.79).56  Patients with DKA in whom the diagnosis of 
diabetes was missed at initial presentation tended to be younger (mean age 5.4 ± 4.4 
years) compared to those in whom the diagnosis was not missed (mean age 8.8 ± 4.0 
years) (P < 0.001).50  Overall, younger children tend to be misdiagnosed with urinary 
tract infections, upper respiratory tract infections, diarrhea/gastroenteritis and otitis 
media.50, 55    
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3. Change in diabetes team  
It has been shown that a change in the diabetes management team can negatively 
impact disease control.150  It is estimated that between 25 – 65% of young adults have no 
medical follow up during the transition from pediatric to adult diabetes care 
services.151,152  In a retrospective Canadian study conducted in 2009, Nakhla et al. found 
that diabetes related hospitalizations rose from 7.6 to 9.5 cases per 100 P–Y in the two 
years following transition to adult care.150  Interestingly, they also found that with 
controlling for all other factors, individuals who were transferred to a new allied health 
care team with no change in physician were 77% less likely (RR: 0.23, 95% CI: 0.05 – 
0.79) to be hospitalized after the transition than were those transferred to a new physician 
with either a new or no allied health care team.150  These findings are integral to future 
studies as patients' lack of trust and satisfaction with their health care providers can lead 
to poor glycemic control162,163 and decreased treatment compliance.161  It is important to 
understand that transitioning from pediatric to adult care is a vulnerable time for patients 
and that time is required to build a solid relationship with a new physician and healthcare 
team.   
 
DISEASE–RELATED FACTORS 
1. Duration of symptoms  
A few studies found that children presenting in DKA at diabetes diagnosis 
compared with those not in DKA had similar mean symptom durations, though the 
symptoms in the group presenting in DKA were slightly shorter, at 16.5 days (standard 
deviation (S.D.) 6.2) versus 17.1 days (S.D. 6.0) respectively, P < 0.001).64,91-93   
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2. Pattern / frequency of symptoms 
It has been found that children with DKA present most often with polyuria, 
vomiting, abdominal pain, dyspnea, weakness, anorexia, and changes in mental 
status.
91,94,96  The EURODIAB study reported that 96% of children displayed polyuria at 
the time of diagnosis of T1DM.84  Two studies also showed that children with T1DM 
with DKA had significantly greater weight loss than those without DKA, 4.84% vs. 
3.32% of body weight (P < 0.0001).84,93  This is consistent with findings described earlier 
that children with known diabetes and lower BMI present in DKA more than those with 
higher BMI, likely due to poor glycemic control associated with restricted weight.69,70  
 
3. Preceding infectious illness  
Patients with diabetes are susceptible to DKA under stressful conditions, such as 
trauma, surgery, or infection.  Worldwide, infection is the most common precipitating 
cause for DKA, occurring in 30 – 50% of cases.30  The presence of a concomitant 
infection may mask the early symptoms of diabetes, resulting in delayed diagnosis and 
increased risk of DKA.47  In addition, an infectious or febrile illness usually increases the 
counter–regulatory response, leading to insulin resistance and metabolic 
decompensation.31         
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4. Sick–day management 
Both the Canadian and American Diabetes Associations have published Sick Day 
Management guidelines to help families dealing with diabetes to manage sick days.141,142  
When the body has an infection, it releases hormones that increase blood glucose levels.  
In addition, during a period of illness one may vomit and/or have diarrhea so monitoring 
fluids is essential.  In addition to the child being ill, sometimes they are left in the care of 
a temporary guardian.  It is crucial for this individual to have sick–day management 
knowledge so that proper care is provided and action can be taken if necessary to prevent 
DKA.  
     
OTHER FACTORS 
1. Time of year 
Two studies found that more cases of T1DM were diagnosed in the winter than 
summer months, however, the rate of DKA cases remained constant (OR 1.07; CI 0.89 to 
1.28, P = 0.49).64,140  It is thought that HbA1C levels are higher in the winter months for 
several reasons.149,166  First, physical activity levels tend to be lower in winter and it is 
thought that physical activity reduces insulin resistance and improves insulin bioactivity.  
Second, people tend to have larger weight fluctuation in the winter, and plasma cortisol 
and tissue sensitivity to glucocorticoids are also higher during this season, which could 
contribute to increased body fat and insulin resistance.167  Individuals with T1DM should 
be especially conscious of managing their disease during the winter to avoid preventable 
complications such as DKA.  
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PROTECTIVE FACTORS  
 
1. Background incidence of T1DM 
 It is hypothesized that background incidence of T1DM has an inverse effect on 
the rate of DKA in newly diagnosed T1DM.38,41,45  Background incidence refers to the 
rate of occurrence of T1DM in a given area.  If the incidence is higher, disease awareness 
and healthcare provision will generally be higher.23,37,84  These insights are thought to be 
attributed to earlier recognition of symptoms and diagnosis.  
 
2. Family history of diabetes 
It is thought that having a family member with diabetes is a preventive factor 
against DKA.  It is assumed to be because there is heightened awareness of the signs and 
symptoms of diabetes, allowing patients to seek care earlier preventing an individual 
from entering into DKA.41,45,47  According to a number of studies,44,65-67 this seems to be 
conditional upon whether the child has existing or newly diagnosed T1DM.  Having a 
first–degree relative with T1DM decreased the frequency of DKA in three studies.44,65,66 
However, having a first-degree relative with T1DM did not predict a diagnosis of new–
onset diabetes before the progression to DKA.67  Further, a small UK study (N=79) 
suggested that children who were the second diabetes-affected child in a family were less 
likely to present in DKA than the first child (OR 0.07; 95% CI, 0.003 – 1.51).68  This is a 
noteworthy finding as it separates the effect of having an increased genetic risk of 
developing diabetes from the environmental effects of having a family member with 
diabetes at the time of diagnosis.  Although high–risk genotypes are associated with 
increased DKA risk, this relationship is unlikely to be solely genetic because it has been 
 35 
shown that having even one first–degree family member with T1DM, there is an 
associated reduced risk of DKA.60  Furthermore, results from a long–term follow–up 
study showed a reduced risk of DKA associated with various environmental factors.61  It 
appears as though this protective relationship is almost certainly due to greater family 
awareness of the symptoms of diabetes, allowing recognition early and prior to 
developing DKA.55   
 
4. Involvement in T1DM prevention research  
It has been shown that enrolment in T1DM prevention research decreases the risk 
of DKA at diagnosis from 30% to less than 4%.134 
 
In conclusion, it is also possible that some of these protective effects could be due 
to clinicians displaying extra caution regarding individuals who have a family history of 
diabetes, as well as variations in access to healthcare, child supervision or schooling.38  It 
is reasonable to consider that if teachers have smaller classes and thus are more involved 
with their students, then they are more likely to look out for the students they know have 
T1DM, resulting in better prevention of DKA.     
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Table 2: Factors influencing the development of DKA 
 
 
2.6 DKA prevention studies   
A number of studies have been conducted to determine the effectiveness of 
education campaigns at reducing DKA in the pediatric population.  While those studies 
have displayed mixed results, there is convincing evidence that improving both 
community and physician awareness of the presenting features of T1DM helps reduce the 
incidence of DKA.  Planning and implementing effective community–based interventions 
requires accurate population–based data on the incidence, hospitalization, and 
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complications of diabetes.29   In this next section, seven published studies on DKA 
prevention and their results will be described (summary provided in Table 6).  
2.6.i Italy   
A DKA prevention study, carried out over the course of eight years in Parma, 
Italy, involved displaying brightly colored posters showing a sleeping child along with 
some simple messages for parents and teachers.76  The relevance of the sleeping child 
image is that the first symptom of diabetes is unusual bed–wetting as reported by 89% of 
parents.77  One thousand posters were displayed in 177 primary and secondary public 
schools of the Italian province of Parma.  During the eight–year study period, these 
schools were attended by a total of 144,736 children aged six to 14 years.  At the 
beginning of each school year, a committee formed by members of the Parents’ 
Association for Diabetic Children and Adolescents of Parma verified whether the posters 
were displayed.  In addition, 60 posters were displayed in 52 pediatricians’ offices 
working in the area and 104 cards with guidelines for the diagnosis of diabetes were 
distributed.  On one side of the card, early symptoms (bed–wetting, nocturia, and thirst) 
and late symptoms (polyuria, polydipsia, weight loss, and fatigue) of emerging diabetes 
were listed and the reverse had the criteria for the diagnosis of T1DM according to the 
World Health Organization.78  Pediatricians were also asked to refer children with the 
above clinical features to the diabetes unit of the department of pediatrics at the 
University of Parma.  To facilitate contact with the diabetes unit, a toll–free number was 
provided to teachers, parents, and pediatricians. 
Each pediatrician was also equipped with devices for the measurement of 
capillary blood glucose and glycosuria, supplies for finger pricking, reagent strips, and a 
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reflectance meter.  Two brief meetings were organized to instruct pediatricians in the 
measurement of capillary blood glucose and to give them more information on the 
criteria for early diagnosis of T1DM and warning signs of the disease.  Nurses and 
pediatricians with experience in managing diabetes oversaw these meetings.   
Clinical features and laboratory values of children six to 14 years old who were 
diagnosed with diabetes in the province of Parma were compared with those of peers 
from the two nearby provinces of Piacenza and Reggio Emilia, where no campaign for 
the prevention of DKA was carried out.  The three above–mentioned provinces are all 
part of Emilia Romagna and are similar in environment, health services, socioeconomic 
status and number of students < 14 years of age.  According to the regional health care 
system, all T1DM patients aged six to 14 years within the areas of Piacenza, Parma, and 
Reggio Emilia must be referred to the diabetes unit of the Department of Pediatrics at the 
University of Parma.  Thus, all newly diagnosed T1DM children six to 14 years old in the 
above–mentioned area were enrolled in the study.  
From January 1, 1991 to December 31, 1997, 148 children aged 45 days to 18 
years with new–onset T1DM were admitted to the department of pediatrics at the 
University of Parma.  Fifty-four (36.4%) of them were six to 14 years old (29 boys, 25 
girls; mean age +/- SD: 8.9 +/-1.4 years).  Of these children, 24 (13 girls, 11 boys; 8.3 +/- 
1.8 years old) came from the province of Parma (group one) and 30 (16 boys, 14 girls; 
8.5 +/- 1.3 years old) came from the nearby provinces of Reggio Emilia and Piacenza 
(group two).76   
DKA was present in three children from group one and in 25 children from group 
two, 12.5% (3/24) and 83.0% (25/30) respectively (X2= 26.8; P = 0.0001).  The three 
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cases of DKA in group one were observed in 1991 (n = 1) and 1992 (n = 2).  Duration of 
symptoms was significantly less in group one than group two (mean five vs. 28 days) and 
impaired level of consciousness was found in only three patients from group two.76  
The total cost of the eight–year campaign was $23,470.  This included costs for 
the posters (26.2%), toll–free telephone line (27%), time spent by nurses and residents to 
answer the phone (34.8%) and educating teachers, parents, and pediatricians (12%).  The 
cost to the national health care system for the treatment and education of inpatients with 
diabetes was $196,457 and $53,356 for children with and without DKA, respectively. 76  
Overall, the prevention program was found to be effective and the cumulative 
frequency of DKA in new–onset T1DM in this area decreased from 78% in the 1987 – 
1991 period to 12.5% in the 1991 – 1997 period.  Further, no newly diagnosed children 
with diabetes ages six to 14 years old from Parma were admitted to the diabetes unit with 
DKA after 1992 until the end of the study.  This result is credited to the prevention 
program because in the two neighbouring provinces where the program was not carried 
out, the incidence of T1DM with DKA was higher and similar to the one observed in the 
province of Parma prior to 1991.  However, despite the promising results, this study was 
limited by its small size, not including children under six and over 14 years of age and 
high baseline rate of DKA compared with typical European rates.   
 
2.6.ii Australia  
  Another study was conducted in Australia during the two–year period between 
March 2010 and February 2012.  The rate of DKA at initial diagnosis of T1DM in 
children <18 years old was determined by a retrospective chart review in Gosford, 
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Newcastle, and Sydney (the Sydney Children's Hospital and the Royal North Shore 
Hospital) for two years prior to the intervention, February 2008 until February 2010. 79  
Gosford was chosen as the intervention site as the population demographics were similar 
to New Castle and Sydney and the practice is for all children presenting with T1DM to be 
admitted to hospitals in the area.   
The campaign involved a mail out to all childcare centers (n=105), schools 
(n=103), and doctors (n=90) in the Gosford area.  This included an explanatory letter, 
four posters and four postcards.  The letter described the study and asked that the posters 
be displayed in plain view of children, parents, childcare workers, teachers and 
physicians.  The letter also explained that the postcards included relevant information on 
common symptoms of T1DM and how to facilitate the timely transport of the child to the 
doctor or emergency department.  The simple poster displayed common signs and 
symptoms of diabetes in children, advice of when to seek medical assistance, and a 
contact phone number.  A diabetes educator offered all childcare centers (n=125), schools 
(n=103), and doctors’ offices (n=90) a visit; however, these only occurred at 67 childcare 
centers, 32 schools, and 12 doctors’ offices.  Physicians were provided with a capillary 
blood glucose meter, a ketone meter and strips.  All emergency departments in the area 
were made aware of the study, but were not visited or educated.  In addition, each year 
the Gosford Division of General Practice included an image of the poster and an 
explanation of the study in a monthly e–mail sent to its members.   
In the two years prior to the intervention (see Table 3 for summary of results), 40 
children presented in Gosford with newly diagnosed T1DM, 15 of whom had DKA 
(37.5%).  During the intervention, 29 children presented with newly diagnosed T1DM 
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and four had DKA (13.8%).  This was a 64% reduction (X2 = 4.74, P < 0.03).79  The four 
children with DKA during the intervention were three males and one female, ages 2.6, 
12.1, 12.9 and 3.5 respectively.79  In the control centers, no contact of any form was made 
with childcare centers, schools, or doctors’ offices.  In these areas, prior to the 
intervention, 123 children presented with newly diagnosed T1DM and 46 had DKA 
(37.4%).  During the intervention period, 127 children presented with newly diagnosed 
T1DM and 49 had DKA (38.6%).79     
 
Table 3: Gosford campaign results 79 
 
  
The reduction in presentation of DKA with newly diagnosed T1DM before 
(n=15) and during (n=4) the campaign in Gosford and the consistent presentation in 
control centers before (n=46) and after (n=49) was attributed to the awareness campaign.  
While the authors did not report exact monetary costs, they did report that the campaign 
was feasible and concluded that it could be implemented in larger centers.  This is the 
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first study to show a reduction in DKA in children aged 0–18 years at initial diagnosis of 
T1DM.79   
 Limitations of this study included that due to a lack of numbers, the authors were 
unable to determine if there was an effect on the rate of DKA in the preschool age 
category.  Second, because of limitations imposed by the ethics committees in the region, 
no formal attempt was made to assess the role of each component of the intervention in 
the reduction of T1DM presentation with DKA.  Further, the authors did not look at DKA 
rates once the intervention had ended.    
 
2.6.iii UK           
    
A third study from Wales was conducted by Lansdown et al. for the period 1991 – 
2009.80  The authors used the Brecon Group (The Welsh Paediatric Diabetes Interest 
Group) register to identify children developing T1DM before 15 years of age living in 
Wales, where all secondary care pediatric diabetes units in Wales contribute to this 
register.  New cases of T1DM were reported, including presentation with 
polydipsia/polyuria or DKA.  Ascertainment analysis showed that the register is > 95% 
complete in each calendar year from 1995 to 2006.80  The proportion presenting with 
DKA were analyzed from 1991 to 2009 by calendar year and age.  The publicity 
campaign was launched on November 15, 2008, based on the one conducted in Parma, 
Italy.76  Posters were sent to every pharmacy (n = 700), school (n = 1833) and general 
practitioners’ offices (n = 500) in Wales.  The headline was “Could Your Child Have 
Diabetes?” and there were a list of key symptoms to detect early signs and symptoms 
associated with T1DM.  The poster also indicated that a simple urine or blood test done 
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by a physician or nurse practitioner could make the diagnosis.  In addition, several radio 
and television interviews were conducted to discuss the symptoms of T1DM and 
diagnosis of the disease.  Over the six months following the launch of the campaign, the 
parents of all children with newly diagnosed T1DM in Gwent (southeast Wales) and their 
general practitioners were asked to complete a post–publicity campaign questionnaire.  
The questionnaire was designed to assess 1) how long the child had symptoms before 
diagnosis, 2) whether cases were admitted via their general practitioner and whether it 
happened immediately or following direct attendance at the emergency department, 3) 
parents’ awareness of the symptoms of diabetes and 4) whether they recalled seeing the 
publicity campaign.80    
The proportions of newly diagnosed patients presenting with DKA two years 
before and one year after the publicity campaign were calculated and comparisons of 
proportions were made by X2 test.  Comparisons were made with data from the Yorkshire 
Childhood Diabetes Register, which covers a population similar in socio – economic 
status but where there had been no such campaign and is sufficiently far enough from 
Wales to not have been influenced by the Welsh campaign.80   
The results of the study showed that in the period two years before the campaign 
(November 2006 – 2007),  36/122 (30%) presented with DKA and one year prior to the 
campaign (November 2007 – 2008), 30/118 (25%) presented with DKA.  In the year 
following the poster campaign (November 2008 – 2009), 30/117 (26%) presented with 
DKA.  The campaign had no significant effect on the proportion of cases with DKA at 
presentation of diabetes (X2 = 0.65, P = 0.72).80  Similar proportions of cases with DKA 
at diagnosis of T1DM were seen in Yorkshire.        
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 The data from this study showed that the mean annual proportion of children with 
newly diagnosed T1DM presenting with DKA in Wales between 1991 and 2009 was 25.  
The study (Table 4) demonstrated that DKA at presentation is more common when 
T1DM is diagnosed before five years of age.  The authors suggested that this age group 
should be targeted in prevention campaigns designed to reduce the occurrence of DKA at 
diagnosis.84,85  Overall, the results of this study show that a campaign with more direct 
engagement of families and health care professionals is likely more effective.  
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Table 4: Welsh campaign results80 
 
 
2.6.iv Austria  
Another study to determine the value of a publicity campaign surrounding T1DM 
and DKA was conducted in Austria over a 22–year period, from 1989 – 2011.  All newly 
diagnosed patients with diabetes ≤15 years of age were prospectively registered by 
the Austrian Diabetes Incidence Study Group.86  This registry covers all pediatric 
hospitals, wards and diabetologists, and case ascertainment is > 93%.86  In September 
2009, a poster campaign was launched similar to the one in Parma, Italy.  Posters 
providing information on the early signs of hyperglycemia and glucosuria were created 
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for both adults and children.  The posters and a letter explaining DKA prevention were 
distributed to all kindergartens (n = 4175), primary and secondary schools (n = 6268), 
and pharmacies (n = 1200).  Further, all Austrian pediatricians and general practitioners 
(n = 15, 700) received posters for their offices along with an article on pediatric diabetes 
that highlighted the symptoms of DKA.  Also, medical journals with articles on pediatric 
DKA were distributed to all medical offices.  During the meetings of the Austrian 
Diabetes Society (fall 2009 and spring 2010) and the Austrian Pediatric Society (fall 
2009), the posters were mounted for all to see.  Another facet of the campaign was the 
education of school medical officers, which occurred twice in 2010.  These education 
sessions included information on the early clinical signs of T1DM and information about 
the DKA prevention program.  As well, in fall 2009, a television broadcast was dedicated 
to the DKA–prevention campaign.  Finally, 18 articles about dealing with the symptoms 
of pediatric diabetes were published in Austrian newspapers between September 2009 
and March 2010, with a theoretical reach of 2,601,500 people.86                  
The frequency of DKA at onset of T1DM in the years prior to the campaign (2005 
– 2009) and after the campaign (2010 and 2011) were compared.  Differences in the 
prevalence of DKA between these time periods as well as time trends were tested with 
the X2 test and logistic regression.  During the 22–year observation period 1989 – 2011, 
4038 children (male, n = 2186, females, n = 1852) younger than 15 years of age were 
registered in the Austrian Diabetes Incidence database.86  The incidence rate of T1DM in 
Austria almost doubled, from 9/100, 000 in 1989 to 17.5/100, 000 in 2011.86  Prior to the 
campaign in 2005 – 2006, 25.9% (95% CI 23.1 – 27.6) of children presented with mild 
DKA, and 12% (95% CI 10.1 – 14.8) with severe DKA.86  Post–campaign in 2010 – 
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2011, a total of 27.5% (95% CI 27.1 – 27.7) had mild DKA and 9.4% (95% CI 9.0 – 9.9) 
had severe DKA.  The frequency of onset of DKA and age at onset were negatively 
associated, (P < 0.01).86   
 
Table 5: Austrian campaign results 86 
 
 
 
 Similar to the study conducted in Wales, the Austrian study also showed no effect 
associated with community education.  The authors stated a number of possible reasons 
for this: 1) posters are not as effective for health care messaging, as compared to when 
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the Parma study was conducted, 2) high baseline DKA prevalence in Parma in 
comparison with the rest of Europe, 3) large geographic region in which the study was 
conducted, 4) short duration of the campaign, and 5) the way in which pediatric care is 
conducted in both countries.  In Austria, primary pediatric care is covered by family 
practitioners who in general have less training in pediatrics, whereas Italy has a 
nationwide primary pediatric network, which allows for a more focused intervention 
program via primary care pediatricians.86  
  
2.6.v US study          
  
This study was conducted in Bronx, New York, during 2011.177  Hospital 
admissions at the Children’s Hospital at Montefiore were used to determine DKA rates 
before and after an education campaign.  The paper is a bit unclear as to when the 
program was launched, however, they state that 2007 – 2010 were pre-intervention years 
and 2012 – July 2014 were considered post-intervention years.  The mean age for the pre-
intervention group was 13.7 years and post-intervention was 14.2 years.    
This study involved both healthcare professionals and patient/public education.  
For the portion of the campaign educating healthcare professionals, the authors aimed to 
have as many certified diabetes educators (CDEs) on the team as possible, including 
nurse practitioners, registered nurses, nurse managers and registered dietitians.  
Certification as a CDE requires that the health care provider have standardized 
knowledge, understanding and experience in diabetes prevention and diabetes care.176  
The teams would meet weekly to discuss patients and each team members’ role in the 
patients’ care.  They created revised criteria for DKA admissions and patients were 
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transitioned from rapid-acting insulin sliding scales to basal-bolus regimens and insulin 
pump use.  The authors concluded that while the initial cost and time commitment for this 
type of therapy is high, its cost-benefit supports its use.174,175  
The next aspect of their campaign was a cross between physician and patient 
objectives.  They increased access for patients by offering more diabetes sessions per 
week, and changed clinic visits from 15 to 30 minutes.  Further, they alternated 
appointments between a nurse practitioner and a physician so a patient’s total diabetes 
visits were at least four per year.  This allowed for patients to see a CDE at different 
times during the day and at sites closer to home.  As well, they offered quarterly 
education sessions for school and home registered nurses.      
The public campaign started with the goal of becoming an American Diabetes 
Association (ADA) recognized program, which promotes the use of diabetes self-
management educations and support.  The diabetes team also used an electronic database 
for tracking individual patients and their specific clinical goals.  Educational materials 
were developed in both English and Spanish.  In addition to patients and their families, 
the campaign also targeted general community education.  There were two annual events 
planned, a Family Diabetes Day and the Candy Exchange.  The diabetes day included 
information on global and local diabetes programs, health lifestyles, insurance and legal 
rights of patients with diabetes.  There were people with diabetes including both public 
figures and other patients that shared their success stories.  The candy exchange event 
involved children exchanging their candy for a toy, and therefore promoted healthy 
eating.   
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DKA admissions decreased from 222 to 120, a 44% reduction post-intervention 
(16.7 vs. 9.3 per 100 P–Y, P = 0.006).  Mean length of stay also decreased from 2 (range 
1 – 47) to 2 (1 – 38), P < 0.0001).  Finally, the authors reported unique patient 
readmissions reduced from 17 (pre-intervention) to 5 (post-intervention),  (P = 0.001).  
Overall, the results of this study demonstrated that implementing a multidisciplinary 
clinical and educational diabetes program for both healthcare professionals and patients 
led to a reduction in DKA admission rates.  
 
2.6.vi France           
   
 A national DKA information campaign for health professionals and families with 
the objective of reducing time to diagnosis was launched in France.179  The article is only 
available in French, however, a summary available in English reported positive results, 
hence its inclusion.  The authors compared frequency and severity of DKA at diagnosis 
of T1DM for one year before the campaign started and for the first year after the 
campaign was implemented.  They only included patients <15 years of age, and found 
that overall DKA rates decreased from 43.9% to 40.5% (P = 0.08) exclusively due to the 
decrease in severe DKA rates from 14.8% to 11.4% (P = 0.01).  Similar to the other 
studies, this group also found a higher rate of severe DKA in the youngest age group (<5 
years).    
2.6.vii Australia   
 There was another diabetes and DKA education campaign offered in Australia 
between April 2007 and February 2012.178 The authors created a structured five–day 
training program for patients on diabetes self-management.  The program was designed 
to be completed in five consecutive days or one day per week for five weeks.  They 
 51 
reported a reduction in DKA admissions from 4.1% - 1.2%.  However, the study 
participants were all older than 18 years of age so this study was not examined further.      
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Table 6: Summary of DKA prevention studies 
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2.6 Newfoundland and Labrador DKA Project (NLdkaP)    
 The NLdkaP was conducted from 2011 to 2012 and involved a series of 
community–based knowledge translation interventions carried out in an attempt to reduce 
the incidence of DKA in NL (Table 7).  In a 2015 NL study, it was reported that 22% of 
new T1DM cases had DKA upon presentation.30 The main objective of the NLdkaP was 
to improve the education of healthcare personnel in NL regarding the early detection of 
T1DM in children, and early detection and proper treatment of pediatric DKA, as well as 
differentiating how the treatment differs from adult DKA.  The second objective was to 
improve the education of families with children and teens with T1DM with the aim of 
preventing DKA.  The third objective was to mobilize a provincial multidisciplinary, 
intersectoral team which included health care leaders, community groups and families 
with the common interest of improving pediatric diabetes care and reducing the burden 
and suffering from pediatric DKA.   
 The project had an advisory committee, which included a teenage patient with 
T1DM, a parent of a youth with T1DM, two diabetes nurse educators, a pediatric 
endocrinologist and diabetologist, and other researchers.   The study aims were reviewed 
and confirmed by the committee.  To educate healthcare personnel and provide them with 
an introduction to early recognition of pediatric diabetes as well as DKA management 
tips and techniques, a continuing education curriculum was developed.  Its aims were to 
allow providers to:  
1. Recognize the signs and symptoms of T1DM and DKA in children and 
adolescents. 
 
2. Identify patients most at risk for DKA. 
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3. Describe the existing clinical practice guidelines, statements, and treatment 
protocols related to pediatric DKA. 
 
4. Explain the risk of cerebral edema and how to prevent and treat its occurrence.     
                                                                                                                                                             
5. Summarize and disseminate the national and provincial initiatives to prevent 
development of DKA in pediatric diabetes.      
  
A course was developed and offered by Professional Development & Conferencing 
Services at Memorial University of Newfoundland (MUN).  Physicians that completed 
the course were eligible for continuing medical education credits.   
The program began with a pre–test, which included questions to establish baseline 
knowledge about pediatric diabetes and DKA.  After these questions, Unit 1: 
Introduction to T1DM was given.  The main points discussed that T1DM is an 
autoimmune disease characterized by the destruction of insulin producing beta–cells of 
the pancreas, it is one of the most common chronic diseases of childhood, some regions 
of Canada have very high rates of T1DM and that its underlying causes are unknown but 
thought to be related to complex genetic and environmental triggers.  Common signs and 
symptoms were described, accompanied by the mnemonic STAT (Figure 6), which was 
developed by the Canadian Diabetes Association.  
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Figure 6: The Canadian Diabetes Association mnemonic "STAT" 144 
 
The next portion of the program was a case study, accompanied by a discussion 
forum and the opportunity to read a sample expert answer.  The take away information 
from the case was that young children with symptoms of diabetes should be investigated 
on the same day by glucose testing in the blood or urine and that the diagnosis of diabetes 
is often not made on initial presentation, which is a missed opportunity for DKA 
prevention.  Unit 2: Diabetic Ketoacidosis discussed the triad of uncontrolled 
hyperglycemia, metabolic acidosis and increased total body ketone concentration which 
characterize DKA, and highlighted the definitions of DKA (mild when the body’s pH 
level is <7.3, moderate when the body’s pH level is <7.2 and severe when the body’s 
level pH is <7.1).  It included information on DKA, how it is preventable in many cases, 
and that it can occur in patients presenting with diabetes for the first time, or in patients 
with pre–existing diabetes.  Reasons for DKA were discussed, e.g., that patients with 
pre–existing diabetes are more likely to develop DKA if there is insulin omission, insulin 
mismanagement and psychosocial factors.  Finally, this unit discussed that younger 
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patients (<5 years of age) are at higher risk to present with DKA upon diagnosis of 
diabetes.  This unit was also followed by a case study, discussion question and expert 
answer.  Unit 3: Management of DKA covered the fact that those presenting with DKA 
require constant and usually intensive care.  Often times, seeking advice from a pediatric 
intensivist, emergentologist, or diabetologist may also be required and most tertiary care 
pediatric centres in Canada have 24–hour on call advice available.  Managing pediatric 
DKA is not that same as adult DKA, as different complications can occur, namely 
cerebral edema.  It is important to start intravenous (IV) insulin 1 – 2 hours after 
initiation of IV rehydration and avoid giving boluses of bicarbonate and insulin.   
Clinical practice guidelines were created so that physicians who infrequently 
diagnose DKA would be able to easily recognize the signs and symptoms (Figure 7).   
 57 
 
Figure 7: Guidelines for DKA management  
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Figure 8: Merck Manual's Pediatric Glasgow Coma scale 153 
The guidelines outlined initial investigations to perform, including important calculations 
to be conducted. Two of these calculations are determining the anion gap and serum 
osmolality. 
Anion Gap  
The anion gap is the difference in the measured cations (positively charged ions) and the 
measured anions (negatively charged ions) in serum. 
Anion Gap = Na − (Cl + HCO3)  
Normal = 12 ± 2 mmol/L  
Pseudohyponatremia  
Pseudohyponatremia occurs because of a shift of water from the intracellular to the 
extracellular compartment secondary to hyperglycemia and increased plasma osmolality. 
There is evidence that hyponatremia may increase the risk of developing cerebral edema 
if blood glucose level declines too rapidly during therapy. 
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Corrected sodium11 = measured Na + 2([plasma glucose −5.6]/5.6) (mmol/L) 145 
Serum osmolality 
Patients who develop cerebral edema have a larger drop in plasma osmolality early 
during therapy.  The changes in plasma osmolality are most prominent during the first 
eight hours after the start of therapy, which appears to be the time window with a large 
risk for the development of cerebral edema.146  Effective osmolality11 = (mOsm/kg) 
2x(Na + K) + glucose (mmol/L)  
The main goals of treatment are to correct dehydration over 48 hours, slowly 
restore blood glucose to close to normal (aim to decrease blood glucose by 3 – 5 mmol/L 
every hour), identify and treat any precipitating event including infection, avoid 
complications of therapy, correct acidosis and reverse ketosis, and minimize the risk of 
complications, especially cerebral edema.  These are achieved through careful fluid and 
salt replacement, insulin therapy and potassium replacement.   
Unit 4: Complications of DKA described the numerous complications that are 
associated with DKA and that these complications are the reason for high DKA 
morbidity and mortality rates.  Reported mortality rates for DKA range from 0.15 to 0.51 
percent in population studies in Canada, the United Kingdom, and the United States.24,145   
Unit 5: Prevention Initiatives reiterated that most cases of DKA can be prevented, 
provided the symptoms are not misinterpreted or misdiagnosed.  The unit highlighted that 
tools such as 24 hour telephone advice for families, home ketone monitoring (blood or 
urine), sick day education (e.g. never omit insulin), and insulin pump troubleshooting 
education are effective in reducing the frequency of DKA in patients diagnosed with 
diabetes.  An overview of insulin pumps was described, as they are a method of insulin 
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treatment using only rapid acting insulin.  In comparison to delivering insulin 
subcutaneously or via meals, if interruption of an insulin pump occurs, deficiency can 
occur within several hours.  There are a number of issues that may occur with this type of 
insulin therapy, such as problems with the infusion site or set, the catheter being 
occluded/bent at insertion site, blocked, torn or leaky tubing, air in the tubing, patient not 
checking sugars to detect hyperglycemia, pump suspended too long, and very rarely, 
pump malfunction.  In addition, not changing the catheter/cannula every two to three 
days can lead to scarring and infection.  Therefore, it is crucial to monitor the pump as 
well as the injection site for these occurrences.  While it is important for health 
professionals to be aware of these possibilities, they also need to continuously educate the 
families that come in with diabetic children so that they can monitor the pump in their 
home settings.  Another prevention technique is education regarding appropriate sick day 
management.  Infections that occur during childhood can sometimes be difficult to 
manage in those with diabetes.  It is essential to have a plan in place for what to do during 
times of intercurrent illness.  Finally, this section concluded with some clinical pearls 
about DKA;  
1. Since most patients develop DKA over days, slow metabolic repair is safest as 
over–hydration may contribute to cerebral edema.  
2. DKA risk factors include younger age, new onset diabetes, children with poor 
metabolic control and/or psychosocial difficulties, infection, and insulin delivery 
issues with insulin pump therapy. 
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3. The goal is to treat dehydration, acidosis and hyperglycemia over 48 hours and 
continually re–evaluate status of hydration, glycemia, acidosis, vital signs and 
mental status. 
4. Large fluid boluses are potentially dangerous: IV fluids should be administered 
slowly and with caution, unless the patient is in shock. Only very rarely will a 
larger (>20 cc/kg) fluid bolus will be required to maintain perfusion. 
5. Insulin Treatment: do not give bolus of insulin and start IV insulin 1 – 2 hours 
after IV fluid initiation 
6. Cerebral Edema: subclinical brain swelling is common in children with DKA. 
Cerebral edema accounts for more than half of the mortality rate of DKA in 
children and risk factors for mortality and DKA include new onset diabetes, age < 
5 years old, severe acidosis and dehydration, rapid rehydration with hypotonic 
fluids (> 50cc/ kg in first 4 hours), insulin given as bolus or in the first hour of 
fluid administration and bicarbonate administration. 
7. With early diagnosis of pediatric diabetes and education of pre–existing diabetes 
families regarding sick–day management and DKA prevention, most cases of 
DKA can be prevented. 
 
The continuing medical education program concluded with ten post–course questions.  
 Another component of the NLdkaP included a qualitative study, which involved  
focus groups with families of children with diabetes.  These focus groups were an 
effective starting point to better understand the issues families face as families have 
unique perspectives that can aid in the information dissemination process.  Since they 
personally have diabetes or live with an individual with diabetes, participants are likely 
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more aware of what is suitable and efficient in a real–world setting.  There were four 
focus groups held in three communities in NL, two rural and one urban with adolescents 
and parents of children/youth with diabetes.  The discussion topics focused on general 
diabetes education, barriers to diabetes self–management, DKA awareness and 
knowledge, personal experiences with DKA and resources that could be developed to aid 
youth in preventing DKA.  The discussions were completed in a semi–structured format, 
leaving room to deliberate on other issues if and as they arose.  Participants were 
recruited through diabetes clinics or diabetes support groups, and the first eight in each 
rural and urban location that met the inclusion criteria were invited to partake.  Written 
consent was obtained from all participants prior to the focus group sessions and written 
assent was obtained from minor participants.  Ethics approval for the project was 
obtained from the Newfoundland and Labrador Health Research Ethics Authority.      
 During the focus groups, a number of barriers were identified.  One of the first 
issues that arose was that people found it difficult to determine if the condition was DKA 
or something else.  Many times the patient had to experience DKA once to know when it 
was occurring for a subsequent time.  Families also commented that some health 
professionals did not identify that their child was experiencing DKA right away either. 
The next theme was diabetes education.  It is inevitable that diabetes education will vary 
in different regions, most likely due to the prevalence in that area.  Regardless, more 
efforts should be placed on ensuring that everyone receives and has access to the same or 
at least comparable information.  It was also stated that the level of information at first 
diagnosis of diabetes could be overwhelming.  Many parents forgot all the details about 
DKA that were given at initial diabetes diagnosis, and just read about it in pamphlets or 
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other materials provided to them.  Another facet of this information overload at the time 
of initial diagnosis is that often times the child is too young to retain any of the 
information or is not included in the information sessions at all; therefore some type of 
subsequent information sessions when the child is older is necessary.    
The next discussion question addressed when children were in the care of 
guardians other than parents.  Parents described episodes of insulin mismanagement 
occurring while the child was in the care of other temporary guardians such as a 
babysitter or grandparent.  Another concern was regarding school time.  Several 
participants reported that their teachers were quite compassionate and understanding, 
however, many students, especially the older ones have multiple teachers per day.  
Educating every single one of them about diabetes care proves to be a very difficult task.  
The next concern was the overall stress of experiencing DKA.  Most of this fell on the 
parents/guardians and was mainly due to lack of understanding/education on the issue 
and some felt they were to blame for the episode.  A lack of resources, specialist care and 
supplies was a barrier that mostly concerned the rural participants, but was a concern that 
the urban participants understood and empathized with.        
 Many of the issues were common amongst all participants, and the following are 
the conclusions from the focus groups.  
1. Diabetes education needs to continue after initial diagnosis.  Often, too much 
information is given at once and not enough is retained.  It would be beneficial to 
have periodic re–education, especially about complications such as DKA. 
2. Some guidelines or quick facts should be available to distinguish between an 
episode of DKA and another illness, e.g. gastroenteritis.  
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3. Youth should have available education tools once they reach an age where they 
begin to separate from their parents/guardians and become more independent.  A 
child with diabetes should have full knowledge of management techniques when 
they are away from their parents/guardians.  
4. Some resources should be available to teachers or other temporary caregivers so 
that the uncertainty of a child’s wellbeing is diminished.   
5. An at–home toolkit for management of blood sugars would be beneficial for 
lowering chance of DKA episodes.  
Overall, it was concluded that DKA is a stressful and traumatic event for both 
youth and their parents.  With the information collected in these focus groups, the second 
objective of the NLdkaP was continued.  An information campaign was developed and 
implemented in all the schools across NL.  This included posters (Appendix A) to remind 
teachers and students of diabetes symptoms, as well as other resources just for teachers.  
These posters were also distributed to all family doctors’ offices, public health offices 
and pharmacies.  There were also information sessions held about DKA with families, 
primary care physicians and hospitals across the province, which covered DKA 
prevention practices.  For example, members of the NLdkaP team visited hospitals 
throughout NL and met with health care professionals during in-person presentations.  
The aim was to provide opportunities for enhanced competencies on early diabetes 
detection, as well as prevention and management of DKA.  These learning opportunities 
and the lessons learned through them laid the foundation of the continuing medical 
education course for healthcare professionals, offered through the Faculty of Medicine’s 
Office of Professional Development and Conferencing Services, MUN.  Treatment 
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protocols were established to help medical staff more efficiently diagnose diabetes and 
manage DKA.  As suggested, a DKA toolkit was created by a local diabetes nurse 
educator, Donna Hagerty.  The toolkits (Figure 9) were available for all families with a 
child with diabetes and the kits included insulin syringes as back up for the pumps, 
ketone strips and instructions for parents if their child has high blood sugar.  
 
Figure 9: DKA prevention toolkits 
Another undertaking of the NLdkaP was visits to the NL branch of the Canadian 
Diabetes Association camp called “Douwanna.”  Further, a calendar depicting artwork 
created by children at this camp was made (Figure 10).  Each month is marked by the 
artwork produced by a child with diabetes, along with a quick diabetes tip.   
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Figure 10: Calendar artwork from camp Douwanna 
   
The third facet of the NLdkaP was the development of videos about DKA made 
by youth with diabetes as a means to share their experiences with the disease.  These 
videos were developed but not widely distributed.  It is believed that this type of 
education will be effective, especially for the adolescent age group that may be more 
receptive to advice and stories from others their own age (peer–to–peer) rather than from 
an adult.   
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Table 7: NLdkaP knowledge translation interventions 
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Chapter 3: Methodology 
 
The primary objective of this research is to study the effect of a multifaceted 
knowledge translation DKA project aimed at educating healthcare professionals, 
families/patients, and the public on the hospitalization rates of children diagnosed with 
DKA in NL.  To achieve this objective, the following research aims were identified:   
 
1. Measure and compare provincial and regional hospitalization rates of pediatric 
patients (aged ≤ 18 years) and young adult patients (aged 19 – 24 years) 
presenting with DKA;  
 
2. Analyze and compare demographic factors of pediatric and young adult patients 
with DKA; 
 
3. Analyze regional patterns of DKA hospitalizations; 
 
4. Determine hospitalization rates and patterns for two years prior, during and two 
years post the NLdkaP. 
 
This chapter will discuss how data were collected, processed and analyzed.  It will also 
discuss the rationale for the assumptions made.   
3.1 Ethical/Administrative Approval  
The Health Research Ethics Authority of Newfoundland approved this study 
(HREB# 2015.270).  Approval for the extraction and use of record–level information for 
secondary uses was obtained from the Newfoundland and Labrador Center for Health 
Information (NLCHI). 
3.2 Study Design  
 This is a pre-post design study.  Patient data was initially collected by their 
respective health care centers and submitted to NLCHI, as per the standard practice in 
this province.29  Patients were stratified by age and sex to determine demographic factors 
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in pediatric and young adult DKA admissions.   The NLdkaP project was aimed at the 
pediatric population. The young adult age group was used as the control–group. 
3.3 Patient Ascertainment  
3.3.i Setting  
 This study took place in the province of NL, which consists of two major 
geographical areas, the island of Newfoundland and a mainland section, Labrador.  The 
island of Newfoundland is the easternmost part of Canada and Labrador is a coastal 
region of the Canadian mainland and the most north-eastern part of continental North 
America.  Patients were assigned to regional health authorities - Eastern, Central, 
Western and Labrador–Grenfell based on the hospital in which they were admitted.  This 
assignment was used to determine regional patterns of DKA.169     
3.3.ii Diagnostic Criteria  
 NLCHI reviewed data on all patients aged 0 – 24 years during the study period, 
January 1, 2009 – December 31, 2014.  Using the International Classification of Diseases 
10th Revision (ICD–10) diagnosis codes, NLCHI identified those patients with a 
hospitalization for DKA during that period.  Hospitalizations for diabetic ketoacidosis 
were defined by ICD–10 codes E1.10 Type ~ diabetes mellitus with ketoacidosis, 
(ketotic) hyperglycemia, ketoacidosis (DKA), ketone formation with acidosis, E1.11 
Type ~ diabetes mellitus with lactic acidosis and E1–.12 Type ~ diabetes mellitus with 
ketoacidosis with lactic acidosis.  These codes were decided upon with the help of 
NLCHI to ensure all relevant patients were included in the study.  
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3.4 Data Collection  
 
The present study includes T1DM subjects, 0 – 24 years of age residing in NL 
during the six–year period, January 1, 2009 – December 31, 2014.  The standard practice 
in NL is to hospitalize all newly diagnosed children with T1DM for initial medical 
treatment, including insulin therapy and family training.29  Also, all patients with 
moderate to severe DKA are admitted, and almost all cases of mild DKA are admitted, 
although a small number of mild DKA may be treated in the emergency department and 
discharged home without admission.  All patients with an admission for DKA during the 
six–year study period, January 1, 2009 – December 31, 2014 were included in the 
analysis for this study. The data was obtained from NLCHI as they collect and store 
hospitalization data that is contained in the clinical database management system 
(CDMS).  The CDMS incudes primary and all other discharge codes of the ICD–10.  It is 
mandatory for all health care facilities in NL to submit discharge abstract data that 
describes inpatient services to the Canadian Institute for Health Information (CIHI).  This 
practice applies to all other Canadian provinces and territories as well.  The data are 
subsequently sent to the provincial Department of Health and Community Services.  
NLCHI maintains the CDMS on behalf of the provincial Department of Health and 
Community Services.  The reliability and validity of this database has been 
documented.168        
Prior to performing any analysis on the dataset, it was reviewed to ensure 
completeness and accuracy.  After running the analysis with the ICD codes described 
above, a total of 831 hospitalizations were identified over the six year period for 0-24 
year olds living in NL.  It was found that amongst the data provided, many patients were 
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diagnosed for other conditions in addition to DKA.  After duplications and 
hospitalizations for other conditions were removed, the revised data had 412 patients 
aged 0 – 24 years of age diagnosed with DKA between January 1, 2009 and December 
31, 2014.  
3.5 Analysis 
  
SPSS Statistics v20 was used.  Poisson distribution was used to calculate 95% 
confidence intervals.  Poisson regression with a linear term for time was used to assess 
the increasing or decreasing trend of hospitalization rates over the study period.  The 
estimated slope from the regression model with a P–value < 0.05 was considered 
statistically significant.  Chi–squared analysis was used for comparison of hospitalization 
rates between sex and hospitalization rates between age groups.  
3.5.i Crude DKA Hospitalization Rate per year during 2009 – 2014, NL  
In order to calculate the crude hospitalization rate for each year,154,155 the total 
number of hospitalizations per year for individuals ages 0 – 24 were totalled and used as 
the numerator.  The mid–year total population was calculated by summing the mid–year 
populations as per the NL Statistics Agency156 for each age group per year of the study 
period and then divided by five to find the average general population for that year.  The 
mid–year population sum was divided by five as there are five different age groups.  This 
number served as the denominator.  The rate was then multiplied by 100,000 to find the 
rate per 100,000.  The hospitalization rates were combined to look at the two years 
before, during and after the NLdkaP.    
Rate = Total Number of DKA Hospitalizations per year  X 100,000   
                     Mid–Year Total Population 0 – 24yrs 
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3.5.ii Age specific hospitalization rates due to DKA per year during 2009 – 2014, NL 
 
  The number of hospitalizations for each of the five age groups were totalled by 
year.  The mid–year population for each year during the six–year study period was taken 
from the NL Statistics Agency156.  The calculated rate was then multiplied by 100,000 to 
obtain the number of hospitalizations per 100,000.     
Age-specific Hospitalization Rate per year154,155 = 
 
 = Total Number of DKA Hospitalizations per age group per year X 100,000 
    Mid–Year Total Population stratified by age group  
3.5.iii Age/Sex Specific Hospitalization Rates due to DKA during 2009 – 2014, NL 
 
In order to calculate the age and sex specific hospitalization rates during the entire 
study period (2009 – 2014), the number of hospitalizations for each age group was 
totalled.  
The average total population for each age group and sex was calculated by using 
the mid–year population for each of the six years during the study period as procured 
from the NL Statistics Agency.156  The mid–year populations for each age group for both 
males and females during each year of the study period were summed and then divided 
by six to get the average population stratified by age group and sex over the study time 
period.  A similar procedure was followed to obtain the average total population.  The 
summed population value was divided by six as the study period was six years long and 
using an average provides more precise population estimates.157  There was no reported 
mid–year population data found for the year 2009.  As a result, an estimate for the 2009 
population was extrapolated from the population data from 2010.  
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Age/Sex Specific Hospitalization Rate154,155 =  
 
Number of hospitalizations stratified by age group and sex X 100,000 
Mid–year population average stratified by age group and sex  
 
The numerator is the number of hospitalizations for each age group and sex 
reported separately and then a total number of hospitalizations for each age group with 
males and females together.  The denominator is the average mid–year population for 
each age group and sex separately and then each age group with males and females 
together.  The resulting calculated value was multiplied by 100,000 to determine the rate 
per 100,000.  
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Chapter 4: Results 
This chapter presents the results from the analysis of hospitalizations during the 
study period.   
4.1 Descriptive Analysis  
   
A total of 412 hospitalizations were included in the study: 244 females and 168 males 
(59.2% and 40.8%, respectively). 
Table 8: Age at admission to hospital for DKA  
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Table 8 illustrates that the largest percentage of DKA hospitalizations were 
amongst those aged 19 and 20 (N = 37 (9.0%) and N = 38 (9.2%), respectively).  The 
smallest percentage of DKA hospitalizations were amongst those aged 7 and 1 (N=2 
(.5%) and N=3 (.7%), respectively). 
 
Figure 11: Age at admission to hospital for DKA  
Table 9: Number of DKA hospitalizations per age category 
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The largest percentage of individuals diagnosed with DKA are those in the 20 – 
24 years of age category followed by the 15 – 19 years of age category.  
 The data were categorized into two age categories, 0 – 19 years and 20 – 24 years 
as the 20 – 24 year olds were not the target of the NLdkaP intervention, and would have 
only indirectly received components of this intervention.  There were 251 DKA 
hospitalizations (60.9%) in the 0 – 19 years of age category and 161 DKA 
hospitalizations (39.1%) in the 20 – 24 years of age category.    
Table 10: Number and % of DKA admissions per healthcare facility 
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As per Table 10, the healthcare facilities throughout the province which had DKA 
hospitalizations include: Bonavista Community Health Centre, Burin Peninsula Health 
Care Centre, Captain William Jackman Memorial Hospital, Carbonear General Hospital, 
Central Newfoundland Regional Health Center, Charles S. Curtis Memorial Hospital, 
Connaigre Peninsula Health Centre, Dr. Charles Legrow Health Centre, Dr. G.B. Cross 
Memorial Hospital, General Hospital – Health Sciences Centre (including the Janeway 
Children’s Hospital), James Paton Memorial Hospital, Labrador Health Centre, Labrador 
South Health Centre, Sir Thomas Roddick Hospital, St. Clare’s Mercy Hospital and 
Western Memorial Regional Hospital. 
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Table 11: Names of hospitals in each region 
  
The hospitals were divided into four regions: East, Central, West and Labrador-
Grenfell (Table 11) as per the Government of NL Regional Health Authorities.169 
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Table 12: Number of hospitalizations in each region 
 
The largest absolute number of DKA hospitalizations occurred in the Eastern 
region (Table 12).   
 
 
Figure 12: Length of stay (days) of hospital admission for DKA  
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In Figure 12, the majority of patients had a length of stay of two nights (n = 116, 
28.2%), followed by those with a one–night length of stay (n = 82, 19.9%).  Sixty 
patients (14.5%) had a hospitalization length of stay of over one week.    
 
Figure 13: Length of stay categories  
Dividing the patients into categories based on their length of stay (Figure 13) was 
helpful in order to visualize the hospital utilization for DKA admissions.  283 patients 
(68.7%) spent up to three days in hospital, 118 patients (28.6%) spent between four – 
nine days, and 11 patients (2.7%) were hospitalized for over ten days.     
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Table 13: Season of hospitalization 
 
  
There was no statistically significant seasonal variability in DKA hospitalizations 
(P=.109) (Table 13).  There were 94 hospitalizations during winter (December – 
February), 92 hospitalizations during spring (March – May), 126 hospitalizations during 
summer (June – August) and 100 hospitalizations during fall (September – November).   
 
Table 14: Recurrent DKA hospitalizations  
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The majority of patients were hospitalized once (n = 159, 68.5%), followed by 
patients hospitalized twice (n = 38, 16.4%) then three times (n = 18, 7.8%) then four 
times (n = 5, 2.2%) then six times and nine times (N = 3, 1.3% each, respectively) then 
seven, eight and 14 times (N = 2, .86% each, respectively).  Overall, 31.5% patients had 
recurrent DKA admissions (Table 14).   
 
4.2 Statistical Analysis          
             
4.2.i Crude DKA hospitalizations per year during 2009 – 2014, NL  
Since the project was implemented for a two-year period, for ease of comparison and 
consistency, DKA admissions reported in two-year periods before, during and after the 
project were used.   
 
 
Figure 14: Crude DKA hospitalizations by two year periods during 2009 - 2014, NL 
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Table 15: Number of DKA hospitalizations per year during 2009 - 2014, NL 
 
 
In 2011 and 2012, when the project was ongoing, the province of NL had the least 
number of DKA admissions N=51 (12.4% of total DKA admissions during study period) 
and N=56 (13.6%), respectively. Compared to 2009/2010 DKA admissions (157/412 = 
38.1%), 2011/2012 DKA admissions (107/412 = 26%) showed a 12.1% decrease.  
Overall, the number of hospitalizations prior to the NLdkaP in 2009 and 2010 were the 
highest, N=90 (21.8%) and N=67 (16.3%).  In the two years post – NLdkaP, 2013 and 
2014, the hospitalizations were slightly lower than before the project N=79 (19.2%) and 
N=69 (16.7%) respectively, but were higher than during the project N=51 (12.4%) and 
N=56 (13.6%).    
  The cumulative hospitalizations for the two years after the project showed an 
overall 38.1% – 35.9% = 2.2% decrease from 2009/2010, but a 35.9% – 26% = 9.9% 
increase from the hospitalizations while the project was ongoing.   
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4.2.ii Age specific DKA hospitalizations per year during 2009 – 2014, NL 
 
Two age categories were compared (0 – 19 years and 20 – 24 years) as the 0 – 19 
year olds were directly targeted by the NLdkaP.   
 
Figure 15: Age specific hospitalizations for age groups 0 – 19yrs and 20 – 24yrs in two-year periods during 2009 – 
2014 in NL  
Table 16: Hospitalization rates between 0 – 19 and 20 – 24 year age groups in two year periods during 2009 – 2014 in 
NL 
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Table 17: Age specific DKA hospitalization rates per year during 2009 - 2014, NL (per 100,000 population) 
 
 
 
Figure 16: Age specific DKA hospitalization rates per year during 2009 - 2014, NL 
 
The above figures and table show the variation in hospitalization rates for the six-
year study period.  Figure 15 demonstrates a reduction in DKA rates for both age groups 
(0 - 19 and 20 - 24) during the NLdkaP.  In the two years post-project, there is a slight 
increase in DKA rates for the 0 - 19 year age group (40 vs. 30) and a larger increase in 
DKA rates for the 20 - 24 year age group (110 vs. 70).  The 20 - 24 year age group shows 
a significant increase in DKA hospitalization rates in 2012.  Table 16 depicts significant 
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hospitalization rates for both age groups, 0 – 19 years and 20 - 24 years, during all time 
intervals of the project.       
 
4.2.iii Age/sex specific DKA hospitalization rates during 2009 – 2014, NL 
 
Table 18: Age/sex specific DKA hospitalization rates during 2009 - 2014, NL 
 
When all ages are combined, there are more female than male DKA 
hospitalizations (P<0.001).  In sub-group analysis of females, there are more female 
DKA hospitalizations in the 10-14 year old age category (P<0.001).  
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Chapter 5: Discussion 
 
DKA is an acute and life-threatening complication of diabetes and is the leading 
cause of morbidity and mortality in children with diabetes.  It is defined as a blood 
glucose concentration of >200mg/dL, with ketonemia/ketonuria and a venous pH <7.3 or 
bicarbonate <15 Eq/L.  The NLdkaP was conducted from 2011 to 2012 and involved a 
series of community–based knowledge translation dissemination activities carried out in 
an attempt to reduce the occurrence of DKA in NL.  The main findings of this study 
demonstrated that hospitalizations for DKA decreased during the intervention phase of 
the project, and the most hospitalized age group was 20–24 years of age.  The results 
from this study will be compared to the published literature as described below.  
The DKA prevention studies identified in the literature review were all developed 
to address physician, patient, family and other caregiver gaps in knowledge.76,79,80,86,177-179  
The studies were multifaceted and incorporated active and passive ways of educating.  
The studies that leaned towards the passive forms of knowledge translation such as 
posters, radio and television advertisements found little to no impact on DKA 
hospitalization rates.80,86  This demonstrates, that perhaps, more integrative methods such 
as education sessions, longer clinic appointments and telephone help lines are more 
effective at relaying information with the goal of reducing DKA rates.76,79,177,178  Most of 
the studies analyzed DKA rates before and after intervention programs, while two 
(including the NLdkaP) looked at DKA rates during the intervention period.  The study 
conducted in Australia monitored DKA rates before and during their intervention but did 
not include any post-intervention analysis.  The lack of consistency across program 
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components such as duration of interventions, follow up periods and ages of participants 
makes it difficult to compare studies and draw conclusions.    
In discussing the individual factor of age, the literature review concluded that the 
largest proportion of DKA hospitalizations were seen in children less than five years of 
age and rates of DKA decreased with increasing age.  Our analysis of the NLdkaP did not 
support this trend.  The studies included in the literature review did not include 
individuals up to 24 years old; the oldest age was 18 years old in the study conducted in 
Australia.  In the NLdkaP analysis, the highest rates of DKA were in the 20 – 24 year old 
category (522 per 100,000) followed by the 15 –19 year olds (350 per 100,000).  It is 
reasonable to conclude that since the NLdkaP was predominantly geared towards the 
pediatric population, this could explain why the rates of DKA were significantly lower 
for this age group.  This may suggest that its impacts were greater in increasing the 
surveillance of new cases of T1DM than addressing the issues of noncompliance with 
insulin management in the older population.   
Adolescence is a time when individuals become more independent from their 
parents/caregivers and many move out to begin university, college, or fulltime work.  
This change in supervisory structure could be accompanied with less insulin regulation 
and may provide an explanation for such a high occurrence of DKA in this age group.  
Further, a number of studies have reported that a change in diabetes management team 
can severely impact disease control.150-152,161-163  A large number of patients develop 
DKA when transitioning from pediatric to adult care so this may also explain the higher 
rates of DKA in the 20 – 24 year old age group during the NLdkaP.  Further, the high 
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rates of DKA hospitalizations in the 20 – 24 year age category are consistent with a 
previous study done in the province by Alaghehbandan et al.29 
A number of the reviewed studies focused on sex and DKA frequencies.29,30,50,64  
These studies determined that females have higher DKA occurrence than males, which 
agrees with the findings from the current study.  Although the reasons for this 
phenomenon are not clear, it is hypothesized that females may be more affected by 
psychosocial issues such as familial conflict, behavioural issues and intentional weight 
loss through insulin omission.74,75  The NLdkaP analysis showed that for all ages (0 – 24 
years of age) there were significantly more females than males hospitalized (244 vs. 168, 
P – value < 0.001), thus concurring with the literature.  In addition, the only separate age 
category to show a significant difference between female and male DKA hospitalization 
was the 10 – 14 years of age (68 vs. 24, P – value <0.001).  This finding is consistent 
with other published literature.  During 10 – 14 years of age, puberty occurs, which is 
associated with hormones that may cause cause insulin resistance leading to poor 
metabolic control.  In addition to this, females are more likely to be affected by eating 
disorders and to omit insulin, which leads to weight loss but also is associated with poor 
metabolic control.74,75  
A number of studies report that more cases of T1DM are diagnosed in the winter 
months compared to other months;64,140 however, in the current study DKA 
hospitalizations remained stable during the year with no seasonal peaks.  The NLdkaP 
yielded slightly more DKA hospitalizations during the summer months, although this was 
not statistically significant.  This could perhaps be attributed to the fact that during the 
summer children spend more time away from their parents and with temporary guardians.  
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Whether it is with a temporary caregiver, playing outdoors, or attending a summer camp, 
it is likely that children are not monitoring their blood glucose levels closely, nor do the 
temporary guardians have all the pertinent information to recognize and attend to the 
symptoms of DKA.  
The reviewed literature concluded that there are no differences between urban and 
rural settings for occurrence of DKA hospitalizations.95,139  The NLdkaP analysis 
determined that the majority of DKA hospitalizations were on the Avalon Peninsula 
(East).  This was an expected occurrence as the majority of the province’s population 
lives on the Avalon Peninsula and it is the location of the Janeway Children’s Hospital, 
the only pediatric tertiary care center in the province. 
 
5.1 Strengths and Limitations  
This pre-post design study helped shed light on a prevalent condition in our 
population in a relatively inexpensive and time-efficient manner.      
There were several notable limitations of the current study.  First, the information 
collected was not specific to the current project, so some pertinent information was not 
collected that could have been useful.  Retrospective studies are subject to confounding 
since other risk factors may have been present that were not measured, and we cannot 
make direct cause-effect assumptions.  Further, we used hospitalization data, which has 
its limitations as well.  This type of data could be subject to incomplete and 
unstandardized information.     
Other limitations of the present study include that information was collected from 
hospitalization data and information like BMI, ethnicity, DKA background knowledge, 
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parental education level, socioeconomic status, family history of diabetes and preceding 
infectious illness were not recorded.  Differentiation between hospitalizations of an 
individual presenting in DKA at diagnosis or not could not be made.  As well, incidence 
could not be calculated from the data, as we were not able to determine if the patient had 
been previously hospitalized for DKA or not.  During the six–year study period, multiple 
DKA diagnoses per individual were recorded as per Table 10.  There may have been 
other factors apart from the NLdkaP affecting reduced DKA rates during the study 
period, such as changes in disease incidence or changes in the population.  Further, there 
may have been cases of prevented DKA that were not measured, as families may have 
managed sick days and insulin delivery problems at home and avoided hospitalization.  
Since it was de–identified data, it was impossible to determine (or ask) if people had 
indeed received information directly from the NLdkaP through a focus group or 
information session, or indirectly through seeing posters, word of mouth, etc.  It would 
have also been helpful to have an idea of how many individuals were reached through the 
knowledge translation project.  There were a number of individuals with greater lengths 
of stay and their files could not be reviewed to determine if they were in hospital for that 
length of time solely for DKA, or because of comorbidity.  As well, there were patients 
with multiple DKA diagnoses during the study period.  With the information collected, it 
could not be determined why these individuals were outliers from the majority that were 
only hospitalized once.  Finally, our analysis was conducted on the impact of the NLdkaP 
program as a whole.  We could not determine if certain parts of the knowledge translation 
program were more effective than others.   
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5.2 Recommendations   
Overall, the study findings demonstrate that the NLdkaP was associated with a 
reduction of hospitalization rates province-wide in pediatric DKA during intervention 
years.  In order to sustain these positive results, ongoing educational campaigns are 
needed as during non-intervention years post NLdkaP, rates of pediatric DKA increased.   
The methods utilized during the project could be implemented longer–term to reduce 
DKA rates and be shared with the young adult age group that have the highest rates of 
hospitalization for DKA.  It would be beneficial to adapt or add in another facet to the 
NLdkaP targeted at the older age groups.  Specifically, arranging organized transition 
services from pediatric to adult care may significantly reduce DKA admissions.  Given 
the advancements in technology since the launch of the NLdkaP, it may also be 
advantageous to discuss the project on the radio, television, and through social media.  
Further, adding a post–publicity campaign survey for both physicians and patients and 
their families would be helpful in determining the efficacy of the intervention and could 
provide insight for methods that were well received and those that could be adjusted.   
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Chapter 6: Conclusions 
 
The alarming rates of T1DM in the province of NL have implications for the 
families living with diabetes and the health care system.  DKA is one of the most serious 
and life–threatening but preventable complications of diabetes.  The high rates of DKA 
place a significant financial burden on the health care system and individual families and 
there is a need for targeted health services for patients and their families.  Continued 
research is warranted to understand the etiology and pathogenesis of T1DM and to 
determine the reasons for such a high disease incidence.  As well, efforts should be 
placed on diabetes education and management.     
 The NLdkaP was launched as a knowledge translation project to better educate 
healthcare professionals and others involved in the circle of care.  The results of the 
analysis show that there was a reduction in provincial rates of DKA during the two years 
the project was ongoing, with an increase in DKA rates after the NLdkaP.  These 
promising results suggest that this type of knowledge translation project was effective 
and could be shared nationally and internationally as a model for DKA awareness and 
prevention. Future research to examine and ensure program sustainability and to evaluate 
its cost-effectiveness is recommended.           
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